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ABSTRACT OF THE DISSERTATION
DEVELOPMENT OF MICRO IMMUNOSENSORS TO STUDY GENOMIC AND
PROTEOMIC BIOMARKERS RELATED TO CANCER AND ALZHEIMER’S
DISEASE
by
Shradha Prabhulkar
Florida International University, 2011
Miami, Florida
Professor Chenzhong Li, Major Professor
A report from the National Institutes of Health defines a disease biomarker as a
"characteristic that is objectively measured and evaluated as an indicator of normal
biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic
intervention." Early diagnosis is a crucial factor for incurable disease such as cancer and
Alzheimer’s disease (AD). During the last decade researchers have discovered that
biochemical changes caused by a disease can be detected considerably earlier as
compared to physical manifestations/symptoms. In this dissertation electrochemical
detection was utilized as the detection strategy as it offers high sensitivity/specificity,
ease of operation, and capability of miniaturization and multiplexed detection.
Electrochemical detection of biological analytes is an established field, and has matured
at a rapid pace during the last 50 years and adapted itself to advances in
micro/nanofabrication procedures. Carbon fiber microelectrodes were utilized as the
platform sensor due to their high signal to noise ratio, ease and low-cost of fabrication,
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biocompatibility, and active carbon surface which allows conjugation with biorecognition moieties.
This dissertation specifically focuses on the detection of 3 extensively validated
biomarkers for cancer and AD. Firstly, vascular endothelial growth factor (VEGF) a
cancer biomarker was detected using a one-step, reagentless immunosensing strategy.
The immunosensing strategy allowed a rapid and sensitive means of VEGF detection
with a detection limit of about 38 pg/mL with a linear dynamic range of 0–100 pg/mL.
Direct detection of AD-related biomarker amyloid beta (Aβ) was achieved by exploiting
its inherent electroactivity. The quantification of the ratio of Aβ1-40/42 (or Aβ ratio) has
been established as a reliable test to diagnose AD through human clinical trials. Triple
barrel carbon fiber microelectrodes were used to simultaneously detect Aβ1-40 and Aβ142 in cerebrospinal fluid from rats within a detection range of 100nM to 1.2μM and
400nM to 1μM respectively.
In addition, the release of DNA damage/repair biomarker 8-hydroxydeoxyguanine
(8-OHdG) under the influence of reactive oxidative stress from single lung endothelial
cell was monitored using an activated carbon fiber microelectrode. The sensor was used
to test the influence of nicotine, which is one of the most biologically active chemicals
present in cigarette smoke and smokeless tobacco.
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Chapter 1
Introduction
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1.1. Motivation
The motivation of the dissertation was to develop sensors to detect disease biomarkers in
patient body fluids and at the surface of single cells. Monitoring disease biomarkers allow
early disease diagnosis as biomolecular changes occur earlier as compared to any
physical symptoms. Disease progression and response to therapy can also be monitored
by measuring biomarkers in patient fluid samples. Electrochemical sensors were used as
the platform technology as they provide several key advantages such as miniaturization,
high sensitivity, and fast response time. The goal of the dissertation was to develop
direct, one-step immunosensors to measure all types of disease biomarkers. Biomarkers
can be broadly classified as electroactive and the non-electroactive biomarkers, as the
platform technology used was electrochemistry.

1.2. Specific Aims
Specific Aim 1: Development of amperometric immunosensor for detection of nonelectroactive biomarkers in patient fluid samples.
More than 90% of the bio-molecules present in the human body are non-electroactive.
Any of these bio-molecules may act biomarkers towards a specific disease. Thus the first
aim of the dissertation research was to develop a highly sensitive, one-step detection
strategy to measure non-electroactive bio-molecules in patient fluid samples. Vascular
endothelial growth factor was used a model non-electroactive analyte as it is highly
overexpressed by tumor tissue.
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Specific Aim 2: Development of amperometric immunosensor for multiplex detection of
electroactive biomarkers in patient fluid samples.
Many interesting biomolecules such as neurotransmitters, prostrate specific antigen,
hemoglobin etc. are electroactive due to the presence of metallic co-factors or active
amino acids such as tyrosine, trytophan, cysteine, and glycine. The second aim deals with
the development of a direct sensing strategy to detect these electroactive biomolecules.
Multiplex detection allows simultaneous detection two or three different biomarkers
which enables earlier disease diagnosis with better accuracy. Electroactive protein
biomarkers – Amyloid beta 40 and 42 related to Alzheimer’s disease were used as model
analytes.

Specific Aim 3: Development of a sensing strategy to detect biomarkers at the surface of
single cells.
Monitoring biomarker release at the surface of a single cell enables the study of the
underlying cause of disease and factors influencing disease progression. Single cells
maintain all their physiological activities and can be monitored without the interference
of other biological components and mechanisms present in the body. In order to study
biomarkers at the surface of single cells, an electroactive DNA damage biomarker known
as 8-hydroxydeoxyguanine was used as the model analyte.

1.3. Biomarkers
Biomarkers comprise of cellular molecules such as proteins or nucleic acids that can be
detected in cells, blood, urine, or other body fluids and are over-expressed due to the
3

onset of disease. To date a wide range of biomarkers have been identified for different
types of diseases and have made their way into translational medicine. These include
DNA modifications, RNA, proteins (enzymes and glycoproteins), hormones and related
molecules, molecules of the immune system, oncogenes and other modified molecules.
The DNA-based markers include single nucleotide polymorphisms (Aly et al., 2011),
chromosomal aberrations (Rossner et al., 2011), changes in DNA copy number (Nakao et
al., 2011), microsatellite instability (Kloor et al., 2005), and differential promoter-region
methylation (Das and Singal, 2004). The RNA-based biomarkers include overexpressed
or underexpressed transcripts, and regulatory RNAs (Sunde, 2010). The protein markers
include cell-surface receptors such as CD20 (Dorner et al., 2010), tumour antigens such
as prostate-specific antigen (Tosoian and Loeb, 2010), phosphorylation states (Moran et
al., 2006), carbohydrate determinants, and peptides released by tumors into serum, urine,
sputum, nipple aspirates or other body fluids. New developments in the fields of
proteomics and genomics research are resulting in the rapid identification of novel
biomarkers. High throughput detection strategies and toxicology studies are enabling the
identification of antigens towards disease diagnosis. Protein micro-arrays, serological
analysis of recombinant cDNA expression libraries (SEREX), and serological proteome
analysis (SERPA) technologies have been successfully used towards the detection of
biomarkers related to cancer and AD. FDA officials are collaborating with researchers
from drug companies, government agencies and academic institutes to develop a list of
validated biomarkers that signal disease progression and drug safety and efficacy.

According to FDA’s draft guidance, there are four different types of biomarkers:
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• Prognostic biomarkers are used to determine the disease progression in a patient.
• Predictive biomarkers are a baseline characteristic that indicate the likelihood a specific
patient will respond to a given treatment.
• Pharmocodynamic biomarkers test the biological response that occurred in a patient
after receiving a particular drug, such as a change in blood pressure or cholesterol.
Drug companies usually test these biomarkers in phase II clinical trials and submit the
results to the FDA; however, actual drug approval is generally based on harder clinical
endpoints.
• Surrogate endpoints are biomarkers that are intended to be used as a substitute for a
clinical efficacy endpoint.
Numerous biomarkers are still going through evaluation to improve their specificity and
sensitivity in the context of their clinical use. The field of biomarker discovery is based
on

a

close

collaboration

between

clinicians,

analytical

scientists

and

chemometritians/statisticians. Defining the final purpose of a biomarker or biomarker
pattern at the onset of a study enables appropriate selection case and control samples,
design of experiments, sample collection, storage and separation protocols, choice and
validation of the quantitative profiting platform followed by data processing, statistical
analysis and validation workflows. Biomarker candidates that result after statistical
validation need be submitted for further validation. Preferably another clinical center
should be assigned to assess the specificity and sensitivity of a given biomarker-based
assay in a larger set of independent samples (Horvatovich and Bischoff, 2010). In order
to make the process of disease biomarker discovery transparent, accessible, and easily
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understood in the context of its conclusions, stringent guidelines have been established
(McShane et al., 2005).
1.4. Biosensor
1.4.1. Historical Survey
Research efforts have focused for the last several decades on improving the “quality of
human life”. Control of disease, quality of food/water and environmental safety are
closely linked to these efforts. The development of biosensors which incorporates the
well established chemical sensing techniques with a bio-recognition element has drawn
the interest of the food-industry, bio-industry, medical, and environmental control
industries. The capabilities of biosensors to combine continuous, selective, high
sensitivity, and fast monitoring make them indispensable (Newman and Setford, 2006).
Clark et al. and others first introduced biosensors in the 1950’s combining physically
entrapped enzymes to an electrochemical transducer (Leland C. Clark Jr, 1962; Sharmat
and Rogers, 1994). During the last several decades the field of biosensors has grown
exponentially with research teams involving researchers with different backgrounds such
as physicists, chemists, medical researchers and engineers.

In a recently published

comprehensive report by Global Industry Analysts, the global market for biosensors is
predicted to reach US $12 billion by the year 2015, with point-of-care testing devices
such as the glucose sensor representing the largest segment (Global Industry Analysts,
2011). Growth in population and the increase in the number of people suffering from
lifestyle related issues such as obesity and diabetes is driving this market growth due to
the need for periodic medical testing. R&D activities related to healthcare are also rising
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with biosensors required for applications such as drug discovery, drug analysis, and for
in-vivo testing of pharmacodynamic effects of new drug candidates.

1.4.2. Definition and classification of biosensor
A biosensor can be broadly defined as an analytical device that converts a biological
response, based on the composition, structure or function of a biological system, into an
electrical signal. Biosensors are often used to determine the concentration of substances
or to monitor a biological system. (Leland C. Clark Jr, 1962).
Biosensor broadly consists of 3 parts:
•

The biological recognition element, which can be, but are not limited to tissue,
microorganisms, organelles, cell receptors, enzymes, antibodies, nucleic acids,
etc.

•

The transducer or the detector element (optical, piezoelectric, electrochemical,
thermal, magnetic etc.) that transforms the signal resulting from the interaction of
the analyte of interest with the bio-recognition element into a signal that can be
measured and quantified.

•

The detector, which consists of associated electronics or signal processors that are
primarily responsible for the display of the results in a user-friendly way. The
detector often accounts for the most expensive and bulky part of the biosensor
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device.

Figure 1.1. A schematic illustration of the functional components of a biosensor.

A successful biosensor must possess most of the following beneficial features:
1. The bio-recognition element must be highly specific for the purpose of the
analysis, and be stable under normal storage conditions.
2. The reaction between the bio-recognition element and analyte of interest should
be as independent of physical parameters such as stirring, pH and temperature.
This would allow the analysis of samples to be conducted with minimal pretreatment.
3. The response of the biosensor should be accurate, precise, reproducible and linear
over a relevant analytical range, without dilution or concentration. The signal to
noise ratio of the biosensor should be high.
4. If the biosensor is to be used for in-vivo monitoring in clinical situations, the
probe must be tiny and biocompatible, having no toxic or antigenic effects. If the
8

sensor is reusable then it should be able to withstand standard sterilization
procedures.
5. The complete biosensor should be cheap, small, portable and capable of being
used by semi-skilled operators.
6. There should be a market for the biosensor. There is no benefit to developing a
biosensor if other factors (e.g. government subsidies, the continued employment
of skilled analysts, or poor customer perception) encourage the use of traditional
methods and discourage the decentralization of laboratory testing.

1.5. Electrochemical Biosensors
Electrochemical sensors have been favored over optical sensors mainly due to numerous
factors such as 1) they are low cost, 2) they can be miniaturized for in-vivo applications
or can be made portable for in-field applications 3) they can be mass-produced using
standard micro/nano fabrication cleanroom facilities. Based on the electrochemical
property to be measured the electrochemical sensors can be classified as potentiometric,
amperometric or conductimetric.
Potentiometric biosensors make use of ion-selective electrodes such as in order to
transduce the biological reaction into an electrical signal. In the simplest terms this
consists of an immobilized enzyme membrane surrounding the probe from a pH-meter,
where the catalyzed reaction generates or absorbs hydrogen ions. The reaction occurring
next to the thin sensing glass membrane causes a change in pH, which may be read
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directly from the pH-meter's display. Typical of the use of such electrodes is that the
electrical potential is determined at very high impedance allowing effectively zero
current flow and causing no interference with the reaction. The basis of this type of
biosensor is the Nerst equation that relates the electrode potential (E) to the concentration
of the electroactive species present in buffer solution.
For the reaction: aA + ne- ↔ bB, the Nerst equation is described as follows:

E = E0 +

RT CAa
{ } (1.1)
nF CBb

Where E0 is the standard redox potential, R is the gas constant, T is the absolute
temperature, F is the Faraday constant, n is the number of electrons exchanged in the
reaction, and CA and CB are the concentrations of the oxidized and reduced species. A
typical application of potentiometric sensors was developed to measure glucose
(Kuffmann and Guibault 1991). Glucose has minimal effect on pH, however the
enzymatically formed product of glucose and glucose oxidase immobilized on the sensor
outer surface of a pH electrodes causes acidification and thus results in a signal change.
Semiconductor based physio-chemical transducers are commonly used in ISFETs (ionselective field effect transistors) and LAPS (light addressable potentiometric sensor)
(Yuqing et al. 2003 and 2005; Yoshinobu et al. 2005). The working principle of the
ISFET sensor is related to a local potential generated at the surface of the sensor by ions
from solution. Potentiometric sensors using semiconductor sensors have been
successfully developed for the detection of herbicide atrazine (D’ Agostino et al., 2006),
neurotransmitter serotonin (Kitade et al., 2004), creatinine (Karakus et al., 2006),
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glycoalkaloids (Korpan et al., 2006), and organophosphate pesticides (Timur and
Telefoncu 2004). The LAPS biosensor has been used for the detection of as low as 10
cells/ml of Escherichia coli and has been commercialized for an automated 8-channel
device for detection of biological agents (Ercole et al., 2002).
Amperometric sensors are based on the measurement of the current resulting from the
electrochemical oxidation or reduction of an electroactive species in solution or at the
surface of the electrode. Amperometric sensors are more sensitive and suitable for mass
production as compared to potentiometric sensors. The working electrode in an
amperometric sensor usually consists of a noble metal such as Pt, Au or a carbonaceous
material such as glassy carbon, carbon paste, screen printed carbon-ink etc.
Amperometric sensors can work in a two- or three-electrode configuration based on the
application. The first case consists of the working (contains bio-recognition element) and
reference electrodes. The main shortcoming of the two-electrode configuration is the
short linear range obtained due to limited control of the potential on the working
electrode surface with higher currents. A third auxillary electrode is employed to solve
this problem. Therefore, in the three-electrode configuration voltage is applied between
the reference and the working electrodes, and current flows between the working and the
auxillary electrodes. Using amperometric sensors in the 3-electrode configuration
currents as low as 10−9 to 10−6 A can be easily measured. The resulting current is directly
correlated to the bulk concentration of the electroactive species or its production or
consumption rate within the adjacent biocatalytic layer. As biocatalytic reaction rates are
often chosen to be first order dependent on the bulk analyte concentration, such steady-
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state currents are usually proportional to the bulk analyte concentration. Amperometric
sensors have often been used on a large scale for detection of analytes such as glucose,
lactate (Ohnuki et al., 2007) and salicylic acid (Marzouk et al., 2007). Biosensors
utilizing enzymes such as acetylcholinesterase and butyrylcholinesterase have been
employed for the rapid detection of organophosphates and carbamates. Detection of
cancer marker genes such as BRAC1 and BRAC2 from breast tissue has been
accomplished using the catalytic oxidation of guanine nucleobase (Tansil et al., 2005).
Amperometric and potentiometric transducers have been used commonly for biosensor
development, but much attention in recent years has been devoted towards impedance
based transducers as they can accomplish label-free analysis. Conductimetric biosensors
follow the changes in conductance or impedance of a solution as a result of the
biorecognition component using a noble element working electrode. Thus the expression
of impedance or its inverse conductance is as follows, where Z is impedance, R is
component resistance, C is component capacitance:

Z 2 = R2 +

1
(1.2)
(2 fC) 2

Conductimetric biosensors include two electrodes with applied alternating voltage,
amplitudes from a few to 100 mV can be used. Biosensors based on the conductimetric
principle present a number of advantages: a) thin-film electrodes are suitable for
miniaturization and large scale production using inexpensive technology, b) they do not
require any reference electrode, c) transducers are not light sensitive, d) the driving
voltage can be sufficiently low to decrease significantly the power consumption, e) large
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spectrum of compounds of different nature can be determined on the basis of various
reactions and mechanisms.
1.6. Electrochemical Methods
Electrochemical methods have been commonly used towards the development of
numerous biosensors, the most famous of which is the glucose biosensor.
Electrochemical analysis involves the measurement of current, potential or charge. The
concentration and properties of the analyte, or the properties of the material used to make
the electrode can be reflected by these measurements. Basic electrochemical methods
involve: voltammetry and amperometry. Variations of these methods such as cyclic
voltammetry, linear sweep voltammetry, square wave voltammetry and constant potential
amperometry are selected to suit the specific application.
1.6.1. Amperometry
Amperometry can be defined as the measurement of a steady-state current in an
electrolytic cell which is due to the oxidation or reduction of the analyte species. There
may be no applied potential (galvanic cell) or there may be an applied potential. In this
later case, a limiting current is established which is proportional to the concentration of
the analyte.
Consider a solution containing the analyte, A, in the presence of some conductive buffer.
If an electrolytic potential is applied to the solution through a working electrode, then the
measured current depends (in part) on the concentration of the analyte. Measurement of
this current can be used to determine the concentration of the analyte directly; this is a
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form of amperometry. However, the difficulty is that the measured current depends on
several other variables, and it is not always possible to control all of them adequately.
This limits the precision of direct amperometry. If the potential applied to the working
electrode is sufficient to reduce the analyte, then the concentration of analyte close to the
working electrode will decrease. More of the analyte will slowly diffuse into the volume
of solution close to the working electrode, restoring the concentration. If the potential
applied to the working electrode is great enough (an overpotential), then the
concentration of analyte next to the working electrode will depend entirely on the rate of
diffusion. In such a case, the current is said to be diffusion limited. As the analyte is
reduced at the working electrode, the concentration of the analyte in the whole solution
will very slowly decrease; this depends on the size of the working electrode compared to
the volume of the solution.
1.6.2. Voltammetry
The common characteristic of all voltammetric techniques is that they involve the
application of a potential (E) to an electrode and the monitoring of the resulting current
(i) flowing through the electrochemical cell. In many cases the applied potential is varied
or the current is monitored over a period of time (t). Thus, all voltammetric techniques
can be described as some function of E, i, and t. They are considered active techniques
(as opposed to passive techniques such as potentiometry) because the applied potential
forces a change in the concentration of an electroactive species at the electrode surface by
electrochemically reducing or oxidizing it. The analytical advantages of the various
voltammetric techniques include excellent sensitivity with a very large useful linear
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concentration range for both inorganic and organic species (10–12 to 10–1 M), a large
number of useful solvents and electrolytes, a wide range of temperatures, rapid analysis
times (seconds), simultaneous determination of several analytes, the ability to determine
kinetic and mechanistic parameters, a well-developed theory and thus the ability to
reasonably estimate the values of unknown parameters, and the ease with which different
potential waveforms can be generated and small currents measured.

1.6.3 Linear sweep voltammetry / Cyclic voltammetry
In linear sweep voltammetry (LSV) a fixed potential range is employed much like
potential step measurements. However in LSV the voltage is scanned from a lower limit
to an upper limit as shown below. The characteristics of the linear sweep voltammogram
depend on a number of factors including:
• The rate of the electron transfer reaction(s)
• The chemical reactivity of the electroactive species
• The voltage scan rate
In LSV measurements the current response is plotted as a function of voltage rather than
time, unlike potential step measurements. The scan begins from the left hand side of the
current/voltage plot where no current flows. As the voltage is swept further to the right
(to more reductive values) a current begins to flow and eventually reaches a peak before
dropping. To rationalize this behavior we need to consider the influence of voltage on the
equilibrium established at the electrode surface. Here the rate of electron transfer is fast
in comparison to the voltage sweep rate. Therefore at the electrode surface equilibrium is
established identical to that predicted by thermodynamics. The exact form of the
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voltammogram can be rationalized by considering the voltage and mass transport effects.
As the voltage is initially swept from V1 the equilibrium at the surface begins to alter and
the current begins to flow. The current rises as the voltage is swept further from its initial
value as the equilibrium position is shifted further to the right hand side, thus converting
more reactant. The peak occurs, since at some point the diffusion layer has grown
sufficiently above the electrode so that the flux of reactant to the electrode is not fast
enough to satisfy that required by the Nernst equation. In this situation the current begins
to drop just as it did in the potential step measurements. In fact the drop in current
follows the same behavior as that predicted by the Cottrell equation. The above
voltammogram was recorded at a single scan rate. If the scan rate is altered the current
response also changes. Each curve has the same form but it is apparent that the total
current increases with increasing scan rate. This again can be rationalized by considering
the size of the diffusion layer and the time taken to record the scan. Clearly the linear
sweep voltammogram will take longer to record as the scan rate is decreased. Therefore
the size of the diffusion layer above the electrode surface will be different depending
upon the voltage scan rate used. In a slow voltage scan the diffusion layer will grow
much further from the electrode in comparison to a fast scan. Consequently the flux to the
electrode surface is considerably smaller at slow scan rates than it is at faster rates. As the
current is proportional to the flux towards the electrode the magnitude of the current will
be lower at slow scan rates and higher at high rates.
Cyclic voltammetry (CV) is very similar to LSV. In this case the voltage is swept
between two values at a fixed rate, however now when the voltage reaches V2 the scan is
reversed and the voltage is swept back to V1. A typical cyclic voltammogram recorded
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for a reversible single electrode transfer reaction is shown in below. Again the solution
contains only a single electrochemical reactant. The forward sweep produces an identical
response to that seen for the LSV experiment. When the scan is reversed we simply move
back through the equilibrium positions gradually converting electrolysis product (Fe2+
back to reactant Fe3+). The current flow is now from the solution species back to the
electrode and so occurs in the opposite sense to the forward seep but otherwise the
behavior can be explained in an identical manner. For a reversible electrochemical
reaction the CV recorded has certain well defined characteristics such as:
1. The voltage separation between the current peaks is ± 59 mV.

2. The positions of peak voltage do not alter as a function of voltage scan rate.
3. The ratio of the peak currents is equal to one
4. The peak currents are proportional to the square root of the scan rate
The Randles-Sevcik equation can be used to predict the peak current obtained from a
reversible redox reaction:
ip = (2.69 x 105) n 3/2 ACD1/2v1/2 (1.3)
where ip is current maximum in amperes, n = number of electrons transferred in the redox
event, A = electrode area in cm2, F = Faraday’s Constant in C mol−1, D = diffusion
coefficient in cm2/s, C = concentration in mol/cm3, ν = scan rate in V/s.
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Figure 1.2. Voltage applied between working and counter electrode with respect to time and the current
response measured at the working electrode during LSV.

Figure 1.3. Voltage applied between the working and counter electrodes and current response measured at
the working electrode during CV.

1.6.4. Square wave voltammetry (SWV)
The excitation signal in SWV consists of a symmetrical square-wave pulse superimposed
on a staircase waveform of step height E, where the forward pulse of the square wave
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coincides with the staircase step. The net current is obtained by taking the difference
between the forward and reverse currents and is centered on the redox potential. The peak
height is directly proportional to the concentration of the electroactive species and direct
detection limits as low as 10–8 M are possible. SWV has several advantages. Among these
are its excellent sensitivity, rejection of background currents and speed of analysis. This
speed, coupled with computer control and signal averaging, allows for experiments to be
performed repetitively and increases the signal to noise ratio. Applications of SWV
include the study of electrode kinetics with regard to preceding, following, or catalytic
homogeneous chemical reactions, determination of some species at trace levels, and its
use with electrochemical detection in HPLC.

Figure 1.4. Square wave voltammetry potential sweep.
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1.6.5. Constant potential amperometry (CPA)
CPA is an electrochemical technique where a constant potential is applied to a sensor
(working electrode) and the faradaic current is measured. This current is generated by the
reduction or oxidation of a chemical substance the electrode surface. The advantage of
this technique is that the time resolution is limited only by the data collection frequency
of the instrument. On the other hand, the primary disadvantage is the low chemical
selectivity. For example, all species with oxidation potentials below the applied voltage
will be oxidized and contribute to the current.
1.7. Carbon fiber microelectrodes
Carbonaceous electrodes have been used for several decades to detect various biological
analytes due to their high electric conductivity, stable background currents, high signal to
noise ratio and signal reproducibility (Kinoshita, 1998). Carbonaceous materials such as
glassy carbon, carbon paste, carbon fibers, graphite and porous carbon have been
employed for several years as electrochemical transducers. Recently, novel materials
such as carbon nanotubes, graphene, carbon nanospheres are have been garnering
attention due to unique electrochemical and mechanical properties (Qureshi et al., 2009).
Carbon fiber microelectrodes were introduced by Pujol et al. nearly 30 years ago, who
used them with normal pulse polarography to measure the oxidation of several
neurotransmitters, including dopamine, norepinephrine and serotonin (Ponchon et al.,
1979). Since then, the most popular applications for carbon fiber electrodes have been as
sensors for in-vivo detection of neurotransmitters. Carbon fiber microelectrodes have
been used for biological applications due to advantages such as:
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•

Excellent biocompatibility and non-toxicity towards cells.

•

Good electrochemical properties which have been extensively studied and
characterized.

•

Miniature size (<10μm in diameter) of electrodes makes them ideal for
implantation with minimal damage.

•

Carbon fiber microelectrodes enable rapid measurements when used with fast
electrochemical techniques such as amperometry, chronoamperometry and fast
scan cyclic voltammetry.

Carbon fiber microelectrodes and electrochemistry have been established as a standard
technique to monitor numerous neurotransmitters such as dopamine, serotonin,
epinephrine, norepinephrine, etc (Troyer et al., 2002; Heien et al., 2004). Thus carbon
fiber microelectrodes have enabled scientists to map the neurochemical activity of the
brain related to disorders such as epilepsy, Huntington’s disease, Parkinson’s disease,
Tourette syndrome, depression, etc (Pacia et al., 2001; Sidlo et al., 2008). Carbon fiber
microelectrodes have also been used to test the pharmacodynamics of drugs in in-vivo
models. Another interesting application of carbon fiber microelectrodes was developed
by Wightman and his colleagues by placing a carbon fiber microelectrode with a 5 μm
diameter at micrometer distances from a living adrenal chromaffin cell; they were able to
monitor exocytosis in real time (Leszczyszyn et al., 1990; Wightman et al., 1991).
Although estranged from their indigenous surroundings, individual isolated or cultured
cells can sustain their characteristic metabolic and neuro(physiological) processes. Thus
single cells can act as good experimental models for examining complex biological
processes and functions in a controlled straightforward manner. Thus single and array
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microelectrodes have been used to measure neurotransmitter, nitric oxide, reactive
oxygen species release from single cells (Schulte and Schuhmann, 2007).

Figure 1.5. Schematic representation of carbon fiber microelectrode components.

Figure 1.6. Actual photograph of carbon fiber microelectrode to appreciate size.
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Chapter 2
Amperometric micro-immunosensor for the detection of tumor biomarker
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2.1. Introduction
VEGF is an important angiogenic factor that plays a crucial role in tumor growth and
metastasis. It is a homodimeric glycoprotein produced by endothelial cells and binds to a
protein receptor in the endothelium vessels, initiating a signaling cascade that ultimately
results in angiogenesis (Kranz et al., 1999) (Kurebayashi et al., 1999) (Ruohola et al.,
1999) (Zhai et al., 1999). VEGF production is increased by tumor cells in response to
stimuli such as hypoxia, abnormal gene activity and activation of other receptors and
pathways in tumor cells. VEGF is overexpressed in a vast majority of human tumors
including lung, thyroid, breast, gastrointestinal tract, kidney, bladder, ovary, etc. Tumor
secreted VEGF initially accumulates on the tumor endothelium (Ferrara and DavisSmyth, 1997). VEGF levels on cell surface and in serum can thus be used as a predictive
factor for malignancy. Furthermore, patients with VEGF-positive tumors have been
shown to have a worse prognosis and early relapse compared to those with VEGFnegative tumors (Masakazu Toi, 1994) (Maeda et al., 1996).
The

current

immunohistochemistry,

techniques

used

enzyme

linked

for

VEGF

quantification

immunosorbent

assays

include
(ELISA),

radioimmunoassay, Western blot, etc. However all these techniques are labor-intensive,
time consuming, require highly trained personnel or expensive equipment. Therefore,
there is a need to develop a suitable detection strategy to carry out real-time, direct,
sensitive analysis of VEGF. The development of a direct, real time detection protocol for
VEGF would enable monitoring serum VEGF levels in patients during therapy to
determine efficacy.
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Detection of biomolecules has been of significant interest in areas such as
genomics, proteomics, medical diagnostics and environmental monitoring. Optical,
mechanical, magnetic and electrochemical sensors have been at the forefront of
biomolecular detection. Electrochemical biosensors have attracted substantial research
efforts due to their high sensitivity, selectivity, miniaturization, low cost, and ease of
operation. They have been used for detecting small amounts of hormones, enzymes,
viruses, tumor antigens, DNA mutants and bacterial antigens (Privett et al., 2008). All
electrochemical biosensors are based on a two component system, which include a
biological recognition element and a signal conversion unit (Leland C. Clark Jr, 1962).
Electrochemical immunosensors use antibodies as their biorecognition elements.
Antibodies offer numerous advantages such as high specificity, versatility, and good
stability. Electrochemical immunosensors operate by measuring either current
(amperometric), potential difference (potentiometric) or capacitance. The measurement of
current is the most common and convenient method used to detect biomolecules.
Amperometric immunosensors can be classified into two different types, as direct and
indirect. Direct immunosensors can be used to detect proteins exhibiting electroactive
amino acids such as tyrosine (Tyr) and tryptophan (Trp) or a metal center with reversible
redox-activity (metalloproteins) (Reynaud et al., 1980, Brabec and Schindlerova, 1981,
Okuno et al., 2007, Armstrong, 1990). However most biomolecules are not electroactive,
hence redox tags are required to enhance their detection. For the detection of nonelectroactive VEGF, ferrocene was chosen as an electrochemical tag due to its special
properties such good stability, and easy chemical modification, (Zhang et al., 2008).
When an appropriate potential is applied ferrocene is easily detectable using voltammetry
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as it rapidly oxidizes without the formation of intermediate products. Zhang et al.,
developed a highly sensitive immunoassay strategy based on the combination of
ferrocene label and poly(o-phenylenediamine) film/gold nanoparticle amplification using
IgG (Immunoglobulin) as the model analyte (Zhang et al., 2008). Akram et al,(Akram et
al., 2006) quantified human chorionic gonadotrophin in clinical samples by measuring
the oxidation of ferrocene linked to a secondary antibody. Ferrocene was used for the
detection of hemoglobin A1c and human chorionic gonadotrophin using flow
immunoassay systems (Tanaka et al., 2007, Lim and Matsunaga, 2001). Ferrocene linked
oligonucleotide conjugates have also been used for the electrochemical study of DNA
and detection of DNA mutants (Ihara et al., 1996) (Nakayama et al., 2002).
The sensing platform employed in the presented work is composed of carbon fiber
microelectrodes which offer advantages such as extremely high sensitivity due to high
signal-noise ratio, enhanced mass transport, and reduced ohmic drop. In addition, the use
of microelectrodes opens up the possibility of in vivo electrical sensing of various
biological compounds in living cells and tissue cultures. Furthermore, the miniaturized
size of the electrode allows the careful selection of the cell or matrix to be investigated
with negligible physical damage to the implanted region. In this regard, the use of a
micro sized electrode also offers a non-destructive way of highly sensitive analysis.
In the present work, we describe a reagentless, electrochemical immunosensing
strategy for an enhanced detection of immunospecies based on the direct oxidation of
ferrocene label. We describe the fabrication of disk shaped carbon fiber microelectrodes
which are immobilized with ferrocene labeled anti-VEGF antibody using a Jeffamine
cross-linker. Upon incubation of these electrodes with VEGF solution, the formation of
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immunocomplexes, leads to a decrease in the electrochemical response of ferrocene due
to increased spatial blocking. This alteration in the electrode response induced by
interfacial immunoreactions was employed to quantify the amount of VEGF. Using the
proposed immunosensing strategy, VEGF could be detected specifically with a low
detection limit and a wide linear dynamic range. The experimental conditions were
optimized, and the performance features such as stability and specificity were also
evaluated. Thus we describe a one-step immunosensing format for the direct detection of
target analytes.

2.2. Experimental
2.2.1. Materials
Carbon fibers (5 μm in dia.) were donated by World Precision Instruments (Sarasota,
FL). Anti-Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor, 2Allylphenol, liquefied phenol (90%), and butyl cellosolve (2-butoxyethanol), reagent
grade methanol, Jeffamine® ED-600, potassium ferrocyanide, potassium ferricyanide,
were purchased from Sigma Aldrich (St. Louis, MO). Borosilicate glass capillaries (outer
dia. 0.5mm, inner dia 0.3mm) were obtained from Sutter Instrument Company (Novato,
CA).

Ferrocene

monocarboxylic

acid

min.

97%,

EDC

(1-ethyl-3-[3-

dimethylaminopropyl] carbodiimide hydrochloride) 98%, sodium perchlorate (NaClO4)
(anhydrous) and Na-HEPES [sodium 4-(2-hydroxyethyl)-1-piperazineethanesulfonate]
were purchased from Fisher Scientific (Pittsburgh, PA). Sylgard 184 was obtained from
Dow Corning Corporation (Midland, MI).
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2.2.2. Instrumentation
Carbon fiber microelectrodes were prepared using P-97 micropipette Puller (Sutter
Instrument Company, Novato, CA). Ferrocene monocarboxylic acid solution filtration
was carried using the Millex-GS (Syringe driven filtration unit, 0.22 μm). Anti-VEGF
was concentrated using the Microcon (Ultracel YM-50, 50 kDa) purchased from Millpore
Corporation (Bedford, MA). Scanning electron microscopy (SEM) was carried out on the
JEOL JSM 5900LV. Electrochemical measurements were carried out using CHI-630A
electrochemical analyzer (CH Instruments, Inc., Austin, TX). A conventional three
electrode cell consisting of an Ag/AgCl reference electrode (3 M KCl) (Bioanalytical
Systems, IN, USA), and a platinum wire as an auxiliary electrode was employed.

2.2.3. Preparation of micro immunosensor
2.2.3.1. Fabrication of disk-shaped carbon fiber microelectrodes
Carbon fiber microelectrodes were fabricated by following the method described by Ates
et al. (Ates et al., 2008). Briefly, a single carbon fiber of diameter 5 μm was attached to
the stripped end of an insulated copper wire (dia. 0.2 mm) using a silver conductive paste.
The silver paste was allowed to dry, after which the free end of the copper wire was
cannulated into a borosilicate glass capillary. The copper wire was fixed to the capillary
using a fast drying epoxy resin. The capillary was then pulled using a micropipette puller.
This pulling procedure results in two glass pipettes, one of which is discarded, and the
other which holds the carbon fiber protruding from its tip. The junction between the
carbon fiber and capillary is sealed with a drop of the Sylgard silicone preparation and
28

allowed to cure until it becomes firm. The protruding fiber was trimmed to a length of
2mm.

2.2.3.2. Insulation of carbon fiber microelectrodes
Carbon fiber microelectrodes were insulated according to the procedure described by
Strein and Ewing (Strein and Ewing, 1992). Briefly, Carbon fibers were insulated using
electropolymerisation of allylphenol in a solution containing 90 mM 2-allylphenol and
60mM phenol. A constant potential of 4.0 V was applied to the carbon fiber
microelectrode vs. a platinum wire counter/reference for a period 14 to 16 minutes. The
polymer coating was then cured by placing the electrodes in an oven at 150 oC for 30
minutes.

2.2.3.3. Preparation of the ferrocene linked anti-VEGF (Fc-anti-VEGF)
The conjugation of ferrocene monocarboxylic to anti-VEGF is carried out as described by
Lim and Matsunaga (Lim and Matsunaga, 2001). Briefly, 4 mg of ferrocene
monocarboxylic acid was dissolved in 800 µl of Na-HEPES buffer (0.15 M, pH 7.3) and
filtered through a 0.22 μm pore filter. 10 mg of EDC and 90 µl of 500 µg/mL anti-VEGF
were then added to this filtered solution and incubated for 4 hours at room temperature.
Removal of unlabeled ferrocene was carried out using ultrafiltration with a Centricon
YM-30 filtration device. After each filtration step the filtrate was collected and analyzed
using UV-Vis spectroscopy. Ultrafiltration was conducted until the peak corresponding to
ferrocene disappeared from the spectra of the filtrate solution (Mina Okochi, 2005).
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2.2.3.4. Modification of carbon fiber microelectrode surface
Fc-anti-VEGF immobilization was carried out by coupling the carboxylic acid (-COOH)
groups found on the carbon fiber to the C terminal of the antibody via a bifunctional
linker molecule (Jeffamine® ED-600). This modification resulted in a stable monolayer
of Fc-anti-VEGF on the carbon fiber surface.

2.2.3.4.1 Activation of carbon fiber surface
Carboxyl groups on the carbon fiber surface were activated by reacting with 4 mg/mL of
EDC in phosphate buffer (0.15 M NaCI, 0.10 M Na2HP04, pH 7.4) for 12 hours.

2.2.3.4.2. Attachment of Fc-anti-VEGF to carbon fiber surface
The electrodes were then dipped into a 0.4 mM solution of Jeffamine ED-600 in aqueous
buffer for 30 minutes. This attaches the hydrophilic spacer arm of Jeffamine to the
electrode surface via an amide bond. Following a buffer wash, the electrodes were then
placed in Fc-anti-VEGF solution for 5 hours at 4 oC. The carboxylic groups present on
the anti-VEGF antibody form amide bonds with the free terminal amines on the surfacebound Jeffamine molecules (Pantano et al., 1991). Thus two amide bonds formed on each
end of the linker molecule assist in the immobilization of anti-VEGF on the carbon fiber
microelectrode surface. Covalent coupling is always preferred as it provides a more
stable and permanent binding of biological materials to the substrate. In the process of
immobilized antibody-antigen molecular recognition, the orientation of the immobilized
antibody and the accessibility of the antigen dictate the interaction between antibody and
antigen. The use of a linker molecule for immobilization has been shown to considerably
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improve both these factors. Jeffamine ED-600 was found to have an optimal length that
resulted in the highest binding efficiency and increase in bio-affinity of immobilized
antibodies (Cao et al., 2007).

2.3. Results and discussions
2.3.1. Characterization of disk shaped Carbon fiber microelectrodes

2.3.1.1 Surface characterization using SEM
Controlling the electroactive surface area of the microelectrodes was a crucial parameter
to achieve reliability and reproducibility. Uncoated cylindrical carbon fibers could not be
used as it is difficult to control the area of the fiber in contact with the electrolyte during
each measurement. Disk shaped microelectrodes fulfilled this requirement as they are
fully insulated and only a uniform circular area corresponding to their diameter is
electroactive. Carbon fiber microelectrodes were fabricated and properly sealed prior to
being insulated by electropolymerisation using a phenol-allylphenol copolymer. The
insulated carbon fibers were then transected using a scalpel blade under a dissecting
microscope to reveal a disk shaped electroactive area. From the SEM images of the disk
shaped microelectrode shown in figure 2.1. it is evident that the insulating layer is well
formed and only the tip of the carbon fiber is exposed.
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Figure 2.1. SEM images of phenol-allylphenol copolymer insulated disk shaped carbon fiber
microelectrodes.

2.3.1.2. Electrochemical characterization
Cyclic voltammetry was performed in 0.03M Fe(CN)6-3/-4 before and after microelectrode
insulation. From figure 2.2 it is evident that before insulation the electroactive area of
each electrode varies however after insulation the electrodes behave in a similar pattern.
The effective radii Reff of these electrodes can be determined from the limiting plateau
currents (Ilim) according to the following equation (Huang and Kennedy, 1995, Zhang et
al., 1999).
Ilim= 2πnFDCReff (2.1)
In the above equation,

‘n’ is the number of electrons transferred during the

electrochemical process, ‘F’ is Faraday constant, while ‘D’ and ‘C’ are the diffusion
coefficient and concentration of the electroactive species, respectively. By using the
known value of the diffusion coefficient of potassium ferricyanide, 7.2×10−6 cm2/s,
(Albillos et al., 1997) the average Reff for the microelectrodes was calculated to be
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approximately 5µm. Carbon fiber microelectrodes with similar surface area were chosen
for further work.

Figure 2.2.A. Cyclic voltammograms of 3 non-insulated carbon fiber microelectrodes. Measurements were
taken in 0.03 mol/L potassium ferricyanide solution. Scan rate was 0.1 V/s and potential limits were from
-1.0 V to +0.4 V vs. Ag/AgCl reference electrode

Figure 2.2.B. Cyclic voltammograms of phenol-allylphenol insulated (disk shaped) carbon fiber
microelectrodes. Measurements were taken in 0.03 mol/L potassium ferricyanide solution. Scan rate was
0.1 V/s and potential limits were from -0.4 V to +0.4 V vs. Ag/AgCl reference electrode

2.3.2. Molecular Assembly of Immunosensor
This work has been directed towards developing a reagentless, electrochemical
immunosensor for the detection of VEGF. The general molecular assembly of the
immunosensor is depicted in figure 2.3. To construct the immunosensor carbon fiber
microelectrodes were used as the sensing platform. Ferrocene tagged anti-VEGF
antibodies were immobilized on the microelectrode surface using a Jeffamine linker.
Covalent attachment of antibody using Jeffamine linker enables covalent attachment
which offers higher stability than physical adsorption methods. Covalent attachment also
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enables better control of antibody orientation, which has been proven to play a key role in
immunosensor performance. Direct oxidation of ferrocene tagged on anti-VEGF which is
attached to the carbon fiber surface gives a measurable signal. The formation of VEGF
and anti-VEGF immunocomplexes leads to spatial blocking and a drop in measured
current. In our work, linear sweep voltammetry for the oxidation of ferrocene
monocarboxylic acid was performed before and after incubation of VEGF with
immunosensor, so that the resultant drop in oxidation peak current could be related to the
amount of VEGF present in sample solution. Traditionally, sandwich formats which
include two antibodies, one to capture the analyte and the other to provide a measurable
signal have been used to create immunosensors. We describe a direct detection method
in which a single antibody tagged using ferrocene performs both the functions of analyte
capture and signaling, enabling a one-step detection platform. The voltammetric
performance of the micro immunosensor is directly influenced by the parameters
involved in its preparation. The incubation time and amount of anti-VEGF immobilized
on the surface are two crucial parameters. Experiments were performed in order to
evaluate and optimize the above mentioned parameters.

34

Figure 2.3. A schematic representing the molecular architecture and working of a micro immunosensor.

2.3.3. Optimization of immobilization conditions

2.3.3.1. Effect of incubation time
The incubation time required for the antigen-antibody immunoreaction is an important
parameter that determines the performance of an immunosensor. Hence, we conducted
experiments to optimize the incubation time. An Fc-anti-VEGF modified carbon fiber
microelectrode was incubated with 5 µL of 200 pg/ml VEGF solution. Linear sweep
voltammetry was then performed in a 0.5 M NaClO4 solution at 10 minute intervals.
From figure 2.4. it is evident that the oxidation peak current keeps decreasing gradually
with the augment of incubation time. After about 40 minutes the peak current stabilizes,
which indicates saturated formation of immunocomplex. Hence an incubation time of 40
minutes was chosen for all further experiments to allow completeness of the
immunoreactions.
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Figure 2.4. Fc-anti-VEGF modified carbon fiber microelectrode incubated with a 200 pg/ml VEGF
solution. Linear Sweep Voltammetry was performed in 0.5 M NaClO4 solution (vs. Ag/AgCl) every 10
minutes. Oxidation peak current is plotted versus responding incubation time.

2.3.3.2. Amount of anti-VEGF immobilized carbon fiber microelectrode surface
To evaluate the amount of ferrocene labeled antibody immobilized on the surface of
carbon fiber microelectrode we rely on the resulting oxidation current from Fc-antiVEGF modified electrode. Linear sweep voltammetry was performed in a 0.5 M NaClO4
solution at a scan rate of 0.75 V/s. In these experiments, 10 carbon fiber microelectrodes
activated using EDC were incubated with different concentrations of Fc-anti-VEGF
solution for about 5 hours at 4 oC. The oxidation current obtained for each of the
electrodes were plotted against the corresponding concentration of the Fc-anti-VEGF
solution with which it was incubated. We observe from figure 2.5. that enhanced binding
of the antibody to the electrode surface was observed during the concentration range of
50- 750 pg/ml. The binding efficiency leveled off for the concentration of 800 pg/ml and
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higher. Hence, for all further immobilization experiments the ferrocene labeled antiVEGF concentration used was 800 pg/ml.
To quantify the amount of ferrocene labeled anti-VEGF immobilized on carbon fiber
microelectrode surface we use the following equation:
Ip=n2F2νAҐ / 4RT (2.2)
where ‘Ip’ is the peak current, ‘n’ is the number of electrons transferred during the
electrochemical process, ‘F’ is Faraday constant, ‘ν’ is the scan rate in V/s, ‘Ґ’ is surface
coverage in mol/cm2, ‘R’ is the Universal Gas constant and ‘T’ is temperature in oK.
Cyclic voltammetry performed in 0.5 M NaClO4 solution with a scan rate of 0.75 V/s,
using an Fc-anti-VEGF modified Carbon fiber microelectrode revealed an oxidation peak
current of 20.4 pA. Using these values in equation (2.2) we obtained surface coverage
values of ferrocene to be 33.3 X 10-7 mol/cm2. To calculate the surface coverage of antiVEGF from that of ferrocene we have to consider that, approximately 12 ferrocene
moieties are attached to each anti-VEGF molecule. Hence the surface coverage of antiVEGF is calculated to be 2.78 X 10-8 mol / cm2.
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Figure 2.5. Three activated Carbon fiber microelectrodes were incubated with 5 µL of PBS buffer, 50, 150,
300, 400, 750, 800, 850, 1000, 1100 pg/ml solutions of Fc-anti-VEGF solutions. Cyclic voltammetry was
performed in 0.5 M NaClO4 solution (vs. Ag/AgCl) after 5 hours. The average value of peak oxidation
current obtained from three microelectrodes is plotted versus the concentration of the antibody solution.

2.3.4. Electrochemical Characterization of Fc-anti-VEGF modified Carbon fiber
microelectrodes.
The voltammetric behavior of Fc-anti-VEGF was studied at different scan rates (0.1 to
0.75 V/s) as shown in figure 2.6. All the voltammograms recorded at different scan rates
exhibited well-defined, symmetrical oxidation and reduction peaks. The oxidation peak
for free ferrocene monocarboxylic acid appears at 0.395 V versus Ag/AgCl (Tanaka et
al., 2007). In our case the anti-VEGF bound ferrocene displays an oxidation peak at 0.52
V versus Ag/AgCl. The shift in peak potential is due to the chemical conjugation of antiVEGF to the carboxylic acid of ferrocene. The redox potential of ferrocene derivatives
depends on the functional groups present in the side chain (Padeste et al., 2000). Both the
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oxidation and reduction peak currents increased linearly with scan rates (figure 2.7.),
which indicates that the Fc always remains on the electrode retaining its electrochemical
activity. The oxidation and reduction peak currents were almost equal, and the potential
difference between the peaks was constant with increase of scan rates showing that the
electron transfer between the ferrocene moieties and carbon fiber microelectrode surface
was relatively fast, indicating a surface controlled process (Zhang et al., 2007).

Figure 2.6. Cyclic Voltammograms of Fc-anti-VEFG modified Carbon fiber microelectrode measured in
0.5 M NaClO4, with scan rates of 0.1, 0.2, 0.3,0.4, 0.5, and 0.75 V/s.
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Figure 2.7. Anodic and Cathodic peak current of Fc-anti-VEGF modified carbon fiber microelectrode in 0.5
M NaClO4 electrolyte.

2.3.5 Detection of VEGF
The micro-immunosensors designed as aforementioned were then incubated with 10
pg/ml to 110 pg/ml solutions of VEGF at room temperature. After incubating the sensor
with sample solutions for a period of 40 minutes, electrochemical measurements were
carried out in a 0.5 M NaClO4 solution at a 0.75 V/s scan rate. From Fig. 2.8., we observe
that when we move from A-J the magnitude of the oxidation current decreases. This
decrease in peak current with increase in VEGF concentration can be attributed to the
increased spatial blocking caused due to the formation of immunocomplexes. The
immunoreactions between VEGF and anti-VEGF causes a blockage to the flow of
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electrons coming from the ferrocene molecules attached to the antibody and traveling to
the carbon fiber sensor surface (Wu et al., 2008). From this observation it is evident that a
fall in peak current is inversely proportional to VEGF concentration in solution.

Figure 2.8. Linear sweep voltammetry responses of Fc-anti-VEGF modified carbon fiber microelectrode to
VEGF at different concentrations. All measurements were performed in 0.5 M NaClO4 versus Ag/AgCl.

A calibration curve obtained by plotting change in peak current (Δ Ipeak) against the
concentration of VEGF is shown in figure 2.9. Based on the plot the sensitivity and
detection limit were found to be 2.047 pA pg/ml and 38 pg/ml, respectively.
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Figure 2.9. Calibration Curve: The linear relationship between change of current response and VEGF
concentration.

2.3.6 Evaluation of electrode stability
We have evaluated the stability of the electrodes over a period of one month. The microimmunoelectrodes were stored in 0.1 M PBS buffer solution at 4 oC after fabrication.
Stability of the designed electrodes was studied by incubating them with 50 pg/ml of
VEGF. Cyclic voltammetry was performed every day before and after incubation. The
activity of the immunosensors was evaluated by measuring the drop in peak current after
incubation. Up to the 24th day the drop in peak current corresponded to the drop expected
for 50 pg/ml of VEGF. From then onwards the activity of the immunosensors kept
declining. This trend suggests that the designed electrodes are suitable for VEGF analysis
up to 24 days.
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2.3.7 Specificity Studies
Specificity is a crucial parameter which influences the performance of an immunosensor
in real matrices. We need to prove that the presented sensor responds only to the VEGF
and anti-VEGF immunoreaction and not to the nonspecific adsorption of other proteins.
In order to demonstrate the specificity of our immunosensor we have incubated our
electrodes with IgG and bovine serum albumin (BSA). Four Fc-anti-VEGF modified
carbon fiber microelectrodes were incubated for 40 minutes with 4 different sample
solutions which include a) 50 pg/ml VEGF, b) 50 pg/ml IgG, c) 25 pg/ml VEGF + 25
pg/ml IgG, and, d) 10 µg/ml BSA in 10mM PBS, respectively. Linear sweep
voltammetry was performed before and after incubation for each electrode. Figure 2.10.
shows drop in peak current after incubation with the sample solutions. It is evident that
there a current drop proportional to the VEGF concentration for samples a and c.
However, samples b and d show no significant changes in peak currents. Hence we can
conclude that the obtained current change was caused due the immunoreactions of VEGF
and anti-VEGF and the presence of other proteins seemed not to interfere with the sensor
performance.
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Figure 2.10. Drop in peak current of 4 Fc-anti-VEGF modified carbon fiber microelectrodes after being
incubated with sample a (50 pg/ml VEGF), sample b (50 pg/ml IgG), sample c (25 pg/ml VEGF + 25 pg/ml
IgG), and sample d (10 µg/ml BSA) in 10mM PBS respectively. Measurements were performed in 0.5 M
NaClO4 versus Ag/AgCl.

2.4. Conclusion
In this work we have successfully designed and characterized a reagentless, miniaturized
electrochemical immunosensing system for the rapid detection of VEGF. In addition,
this single use sensor requires no sample preparation for measurement of VEGF in
patient fluid samples. The detection mechanism is based on the measurement of
electrochemical signal changes induced by the interfacial immunoreactions of surface
immobilized ferrocene linked anti-VEGF antibody probes with VEGF present in solution.
A detection limit of about 38 pg/ml for VEGF is obtained in this work which is sufficient
to detect VEGF in plasma of normal subject (138 pg/ml) and cancer patients (435445pg/ml) (Karayiannakis et al., 2002). Further, a similar detection strategy can be
applied towards the detection of any non-electroactive biomolecules by using an
appropriate antibody. Therefore the detection strategy is applicable towards most
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biomolecules present in patient fluid samples and can be used to obtain diagnostic,
prognostic or therapy response related information. The limitations of the detection
strategy are the long response time (45 minutes), need to redox probe (ferrocene) to
provide an indirect measurement of biomarker binding, and single-use capabilities. In
order to resolve these disadvantages a direct detection strategy was developed as
described in Chapter 3.
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Chapter 3
Electrochemical Sensor for Multiplex detection of Amyloid Beta 40 and 42 for
Alzheimer’s Disease Diagnostics
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3.1. Introduction
Alzheimer’s disease (AD) is one of the most common neurodegenerative diseases
currently affecting about 5.3 million people in the United States alone (Herbert et al.,
2003). The national cost of caring for AD patients is ~ 100 billion each year. Despite
important advances in the understanding of AD, much is still unknown about the
underlying cause of the disease. Aβ peptide compries of 39-42 amino acids is the primary
constituent of plaques found in the brain of patients suffering from AD. These insoluble
plaques hinder the communication between neurons causing cell death, cognitive
dysfunction, and behavioral abnormalities, they also initiate a host of other events
including inflammation and tau aggregation as neurofibrillary tangles (Hardy and
Higgins, 1992; Murphy and LeVine, 2010). However, till date there is no inexpensive,
sensitive, real time detection strategy for monitoring Aβ in-vivo which can ultimately
answer critical questions regarding its production, accumulation and clearance under
physiological and patho-physiological scenarios. The growing potential of the Aβ ratio to
act as a biomarker in diagnostic, prognostic, and therapeutic research studies warrants a
better understanding of its biochemistry (Andreasen et al., 1999; Hampel et al., 2010;
Blennow, 2004). There is still a significant amount of research required to completely
understand the link between Aβ and the underlying cause of AD. Assessment of the
interstitial and cerebrospinal pools of Aβ may provide unique insights into the regulation
of Aβ aggregation and plaque formation (Bibl et al., 2007; Tampellini and Gunnar,
2010). Studies of this nature have been previously performed in-vitro on neuronal cell
cultures and brain slices using fluorescence microscopy and ELISA (Wyss-Coray et al.,
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2003). Towards in-vivo Aβ measurements, microdialysis has been the most commonly
utilized technique for the past 10 years (Cirrito et al., 2005).
This work has been directed towards the development of an electrochemical
immunosensor capable of simultaneously detecting two Aβ isoforms using the intrinsic
electroactivity of Aβ (Vestergaard et al., 2005). Aβ contains a single Tyr residue at
position 10, bearing a phenolic group, which is easily oxidized at the electrode surface
(Chikae et al., 2008). Carbon fiber microelectrodes were used as the platform sensor as
they offer advantages such as high signal to noise ratio, biological compatibility, and
miniature size (Armstrong-James and Millar, 1979). Carbon based electrodes have been
proven to sensitively detect Tyr oxidation (Okuno et al., 2007; Kerman et al., 2006).
Using SWV the voltage applied to the carbon fiber microelectrode was scanned within a
window of -0.2 V to 1.0 V. The voltammogram shows increase/peak in measured current
due to the oxidation of electroactive species, when the electrode attains the corresponding
oxidation potential. When the electrode scans through 0.6 V, Tyr residues present in Aβ
oxidize which causes up to 4 electrons/molecule to be released that are detected by the
electrode as increased/peak current. While 0.6 V can cause oxidation of a variety of
molecules, including all nearby tyrosines, an antibody covalently attached to the
electrode surface can provide specificity for a particular target such as Aβ. By monitoring
the intrinsic electrochemical activities of Aβ, direct, real-time, and reagentless detection
is possible.
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3.2. Materials and Methods
Carbon fibers (5 μm in diameter) were donated by World Precision Instruments
(Sarasota, FL). Borosilicate glass capillaries (3 barrels, inner diameter 1.0 mm) were
obtained from Sutter Instrument Company (Novato, CA). Sylgard 184 was obtained from
Dow

Corning

Corporation

(Midland,

MI).

1-ethyl-3-[3-dimethylaminopropyl]

carbodiimide hydrochloride (EDC) and N-hydroxysulfosuccinimide (NHSS), EZ-Link
Plus Activated Peroxidase was purchased from Thermo Fisher Scientific Inc. (Rockford,
IL). Aβ antibodies (mHJ2, mHJ7.4, mHJ5.1) were donated by Dr. Cirrito’s laboratory.
Aβ1-40 and Aβ1-42synthetic peptide were obtained from American Peptide Company
(Sunnyvale, CA). MES buffer, 3,3′-diaminobenzidine (DAB), hydrogen peroxide (H2O2),
sodium chloride, and other reagents were purchased from Sigma–Aldrich (St. Louis,
MO).

3.2.1. Instrumentation
Carbon fiber microelectrodes were prepared using P-97 Micropipette Puller and BV-10
Beveller acquired from Sutter Instrument Company (Novato, CA). Microelectrode
activation and electrochemical measurements in connection with CV, differential pulse
voltammetry (DPV) and SWV were carried out using the 600C Electrochemical Analyzer
attached to a Picoamp Booster from CH Instruments, Inc. (Austin, TX). SEM of the triple
barrel microelectrodes was carried out on the JEOL JSM 5900LV. The cyclic square
wave E-field was applied using the Leader LFG-13005 function generator and monitored
using the Lafayette-82418 oscilloscope. A conventional three electrode cell consisting of
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an Ag/AgCl reference electrode (3 M KCl) (Bioanalytical Systems, IN, USA), and a
platinum wire as an auxiliary electrode was employed.

3.2.2. Fabrication of Triple Barrel Aβ1-40/Aβ1-42 Sensor
Triple barrel carbon fiber microelectrodes were fabricated using the same method as
described in our previous work. Briefly, a single carbon fiber of diameter 5 μm was
attached to the stripped end of an insulated copper wire (diameter 0.2 mm) using a silver
conductive paste. Each barrel of the borosilicate glass triple barrel capillary was then
cannulated with a carbon fiber attached copper wire. The three copper wires were then
fixed to the capillary using a fast drying epoxy resin. The capillary was then pulled using
a micropipette puller. This pulling procedure results in two glass pipettes, one of which is
discarded, and the other which holds three carbon fibers protruding from its tip. The
junction between the carbon fibers and capillary is sealed with a drop of the Sylgard
silicone preparation and allowed to cure until it becomes firm. The microelectrodes were
then beveled at 45° using a diamond abrasive plate, to obtain three disk shaped electrodes
which are completely isolated from each other. The surface of the electrodes was cleaned
by 5 s sonication in acetone, 1 M nitric acid, 1 M KOH and distilled water sequentially.
To facilitate the binding of capture antibody, the microelectrodes were electroactivated
using a 150 mM NaCl solution (pH=10) at 1.2 V (vs. Ag/AgCl) for 8 minutes at room
temperature. 0.4 M of EDC and 0.1 M of NHSS solutions in 0.1 M MES buffer (pH=6)
were then sequentially applied for 20 minutes to activate the carboxylic groups on the
carbon fiber surface by forming a semi stable amine reactive NHS ester. The
microelectrodes were then placed sequentially in mHJ2 (specific to Aβ1-40) (E1(40)),
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mHJ7.4 (specific to Aβ1-42) (E2(42)), and mHJ5.1 (specific to all isoforms of Aβ)
(E3(TOT)) antibody solutions and a cyclic square wave E-field (–0.3 V to +0.3 V, 0.1
Hz, 10 minutes) was applied sequentially to each electrode versus a platinum wire
cathode. Application of the E-field allows for the selective placement of mHJ2 on E1,
mHJ7.4 on E2(42) and mHJ5.1 on E3(TOT). Electrodes were incubated in 0.1 %
ethanolamine solution to block any non-specific binding sites. In order to obtain
quantitative measurements about the amount of antibody conjugated to the electrode,
horseradish peroxide (HRP) labeled antibodies were utilized. Labeling of Aβ antibody
(mHJ5.1) to HRP was performed as per protocol specified by Thermo Scientific. DAB
and H2O2 were used as the substrates in HRP catalysis reaction and measurements were
conducted using DPV (Zhang et al., 2008). Crucial parameters related to efficient
antibody immobilization such as antibody solution concentration, E-field parameters, and
immobilization time were optimized based on the HRP based electrochemical results.

3.2.3. Measurement of Aβ1-40 and Aβ1-42 in cerebrospinal fluid (CSF) solutions
Aforementioned micro-immunosensors were then challenged using rat CSF solutions
spiked with different combinations of Aβ1-40 and Aβ1-42 within a range of 10 nM to 2
μM. A cyclic square wave E-field (+0.75 to -0.75 V, 50 Hz, 10 minutes) was applied
simultaneously to each of the three electrodes in order to accelerate the incubation
process. The electrodes were rinsed twice with PBS buffer (pH = 7.2) to get rid of any
randomly or loosely attached Aβ molecules. SWV was used to simultaneously evaluate
the

response

of

each

of

the

three

microelectrodes
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before

and

after

the

immunoreactions.SWV voltammetry was performed using 10 mM PBS and 1 mM KCl as
the supporting electrolyte.

3.3. Results and Discussion
3.3.1. Molecular architecture of the immunosensor
Here we report the development of a real-time immunosensor which can perform highly
sensitive Aβ measurements. The general molecular architecture and working principle of
the immunosensor is shown in Fiure 3.1. To construct this immunosensor, 3 distinct
antibodies were placed on each of the barrels of the carbon microelectrode. Antibodies
mHJ2 placed on E1(40) and mHJ7.4 placed on E2(42) are highly specific to the detection
of Aβ1-40 and Aβ1-42 respectively. Antibody mHJ5.1 which binds to the central region
of the Aβ peptide can capture all Aβ isoforms and thus acts as a positive control for the
immunosensor. The function of antibodies in the developed immunoensor is three-fold
and needs to be explained in detail. 1) Antibodies capture/bind Aβ molecules to the
sensor surface which decreases the electron tunneling distance between the sensor surface
and the Aβ molecules. The decrease in the tunneling distance allows for electrons
generated due to the oxidation of Aβ to travel to the sensor surface during SWV and
generate a current signal. Therefore lower quantities of Aβ can also generate a
measurable signal and improve sensor performance. 2) The capture/binding of Aβ to the
surface of the carbon fiber eliminates cross talk between the 3 microelectrodes during
simultaneous measurements of Aβ1-40 and Aβ1-42. 3) Antibodies also enable highly
specific detection of Aβ1-40 and Aβ1-42.
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In this work SWV for the oxidation of Aβ was performed so that the magnitude of the
resultant oxidation peak could be related to the amount of Aβ1-40/42 captured by the
specific antibodies onto the electrode surface. Parameters involved in the preparation of
an immunosensor play a vital role on its voltammetric response. Therefore, the
immunosensor was optimized for a maximum voltammetric response by optimizing key
parameters such as amount of antibody immobilized on the electrode surface and
incubation time. A cyclic square wave E-field was applied in order to accelerate the
movement of antibodies towards the electrode surface which resulted in faster
immobilization time.

Figure 3.1. Schematic illustration of the microbioelectronic detection system for Alzheimer’s disease
related Aβ1-40 and Aβ1-42 peptides.

3.3.2. Characterization of fabricated triple-barrel carbon fiber microelectrodes
Carbon fiber microelectrodes have previously been employed for the direct
electrochemical evaluation of neurotransmitters, enzymes, etc. In addition, the use of
microelectrodes opens up the possibility of in-vivo application of the immunosensor. The
miniaturized size of the electrode (several microns in diameter) would allow the careful
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selection of the biological matrix to be investigated with negligible physical damage to
the implanted region (Huffman and Venton et al., 2008). Figure 3.2 shows the image of a
triple barrel carbon fiber microelectrode obtained using SEM. The SEM image of the tip
of the electrode shows three distinct disc shaped carbon fibers embedded in an epoxy
matrix. From the SEM images each of the carbon fibers can be estimated to be 4-5 µm. In
order to precisely quantify the effective working area of each electrode, cyclic
voltammetry was conducted. Based on Randles-Sevcik equation (Ipa=(2.69 X 105) n3/2
AD1/2 v1/2Cred), the electroactive area (A) of all electrodes was determined from the
anodic peak current (Ipa) obtained in the cyclic voltammograms conducted using 0.03M
Fe(CN)6-3/-4 (Cred) at a specific scan rate (v) as shown in figure 3.3. The diffusion coefficient (D) was taken to be 6.5 X 10-6 cm2s-1 at 20 oC as derived by Kakuichi et al.,
2002 and the average effective working area for each of the microelectrodes was
calculated to be approximately ~5 μm.

Figure 3.2. SEM image triple barrel carbon fiber microelectrode.
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Figure 3.3. Cyclic voltammograms of the three barrels of a microelectrode. Measurements were taken in
0.03 mol/L potassium ferricyanide solution. Scan rate was 0.1 V/s and potential limits were from 0.0 to
+0.8 V versus Ag/AgCl reference electrode.

3.3.3. Optimization of antibody immobilization parameters
In the development of electrochemical immunosensors the immobilization of the biorecognition element on the electrode is critical towards sensor performance. The surface
of carbon fibers is well known to exhibit many reactive sites including hydroxylic,
phenolic and carboxylic functionalities (Pantano and Kuhr, 1991). In order to expose
these groups, the carbon fiber microelectrodes are electrochemically pretreated
(Prabhulkar and Li, 2010). The microelectrodes were electroactivated using a 150 mM
NaCl solution (pH=10) at 1.2 V (vs. Ag/AgCl) for 8 minutes at room temperature. The
next step towards the construction of the immunosensor was to employ a carbodimide
reaction to selectively attach the three antibodies on the surface of each of the barrels of
the microelectrode. In order to test binding of the antibody to the electrode surface, we
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first conjugated HRP to the antibody. HRP provides a large oxidative signal that is easily
detected by the electrode; HRP-labeled antibodies were only used to test for antibody
absorption to the electrode. This involved the incubation of the pretreated
microelectrodes in EDC and NHSS solutions. Initially the EDC and NHSS solutions were
prepared in PBS buffer; however a negligible amount of antibody was bound to the
electrode surface as measured by the electroactivity of the HRP label. We therefore
switched the buffer to MES which showed a much higher peak from the HRP-labeled
(mHJ5.1) antibodies as seen in Figure 3.4

.
Figure 3.4. DPV response obtained from HRP labeled antibodies immobilized using PBS and MES buffer
solutions.

HRP-labeled (mHJ.2) antibodies were used to optimize the parameters of the cyclic
square wave (CSW) E-field which was applied to accelerate the incubation process by
promoting the transport of the antibodies to the electrode surface (Wei et al., 2009). The
CSW E-field creates a mass transportation effect in the incubation solution which creates
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good mixing in shorter time as compared to diffusion kinetics. The voltage applied to
three electrodes was varied from ±0.1 V to ±0.5 V for equal positive and negative
cycles. The electrodes were monitored by conducting DPV at every 1 minute interval for

a period of 12 minutes. Based on the data shown in Figure 3.5 and 3.6 the optimum
incubation time and applied voltage were chosen as ± 0.3 V and 7 minutes respectively.

Figure 3.5. Bare triple barrel carbon fiber microelectrode incubated with a 1.5 μg/ml solution of HRP
labeled anti-Aβ antibody (mHJ5.1) solution. DPV was every 1 minute performed using 10 mM PBS buffer
and 1 mM KCl as supporting electrolyte. Oxidation peak current is plotted versus responding incubation
time.
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Figure 3.6. Effects of driving potential on the amount of antibody immobilized on electrode surface using
1000 μg/ml antibody solution and incubation time of 7 minutes.

During the immobilization of antibodies on the immunosensor, only a fraction of the total
antibody applied gets bound to the electrode surface. In order to conserve a precious
resource such as anti-Aβ antibodies, the optimal concentration was established
empirically. In these experiments, an electrochemically activated and pretreated
microelectrode was incubated in solutions ranging from 0.1 to 1.5 µg/ml of mHJ5.1
antibody. The binding efficiency peaked and plateaued when more than 0.8 µg/ml of
mHJ5.1 antibody was applied as shown in Figure 3.7. The low binding efficiency can be
attributed to the presence of hydroxylic and phenolic groups in conjunction to the
carboxylic groups which are not activated by EDC/NHSS and do not bind antibodies.
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Figure 3.7. HRP signal generated by electrode following the application of an increasing load of HRP
labeled antibody.

3.3.4. Immunosensor Performance
After completing the optimization of key steps in the molecular architecture of the sensor,
we assessed the ability of the immunosensor to simultaneously quantify Aβ1-40 and
Aβ1-42 in CSF solutions using SWV with 10 mM PBS and 1 mM KCl as the supporting
electrolyte. Figure 3.8. shows the voltammetric response obtained after the incubation of
the microelectrode with four solutions containing equal concentrations of Aβ1-40 and
Aβ1-42 (0 nM, 100 nM, 500 nM and 1 µM) spiked into rat CSF. In each case when the
potential was scanned between 0.0 to 0.8 V, a well-defined voltammogram consisting of
an oxidation peak between 0.6 to 0.65 V was obtained. The oxidation current was
obtained almost instantaneously in our experiments with no delay needed for equilibrium.
Further, no stringent temperature control was required during electrochemical evaluation.
The signal obtained for E3(TOT) which acts as the control electrode was always higher
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as compared to the signals obtained for E1(40) and E2(42). The response obtained for
E3(TOT) correlates with the activity of the mHJ5.1 antibody which recognizes most
isoforms of Aβ as it is targeted towards the central region of the peptide.

Figure 3.8. Square wave voltammetric responses of 3 barrel of the immunosensors obtained in rat
cerebrospinal fluid solution, spiked with 100 nM Aβ1-40 and 100 nM Aβ1-42, 500 nM Aβ1-40 and 500
nM Aβ1-42, 1 μM Aβ1-40 and 1 μM Aβ1-42 solutions. Square wave voltammetry parameters: Init E (V)
=1; Final E (V) =0; Incr E (V)= 0.004; Amplitude (V) = 0.04; Frequency (Hz) = 500.

Linear calibration plots shown in figure 3.9A and 3.9B were then constructed based on
peak oxidation currents obtained vs. Aβ1-40 and Aβ1-42 concentrations respectively, in
order to normalize the variations between electrodes. Based on the evaluation of the
calibration plots Aβ1-40 and Aβ1-42 could be specifically detected in CSF from rat
within a detection limit of 400 nM to 1 μM and 100 nM to 1.2 μM respectively. The
discrepancy observed with the detection capabilities of the immunosensor towards Aβ160

40 and Aβ1-42 detection might be for several reasons including: 1) related to the inherent
immunoreaction kinetics of each antibody, 2) differential aggregation of Aβ which could
limit signal multimers, 3) more non-specific absorption (“sticking”) of Aβ1-42 versus
Aβ1-40 to the apparatus.

Figure 3.9. (A) Calibration curve: the relationship between peak oxidation current and Aβ1-40
concentration. (B) Calibration curve: the linear relationship between peak oxidation current and Aβ1-42
concentration.

Specificity is a crucial parameter which influences the performance of an immunosensor
in real matrices, especially when an analyte at low concentrations needs to be detected in
the presence of a much larger concentration of non-specific molecules. We need to prove
that the presented sensor responds only to the Aβ and anti-Aβ immunoreaction and not to
the nonspecific adsorption of other proteins. CSF contains free tyrosine and other
proteins containing tyrosine amino acid residues, which could cause false signaling.
Ethanolamine which has been proven to be a successful blocking agent in previous
studies (Frederix et al., 2004) was used to minimize these non-specific binding reactions.
In order to measure the specificity of each of the barrels towards a specific Aβ isotope,
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three immunosensors were challenged using each of the following solutions 1) 1000 nM
Aβ1-40 2) 1000 nM Aβ1-42 and 3) 500 nM Aβ1-40 and 500 nM Aβ1-42. SWV was
performed before and after incubation of each microelectrode with analyte solution.
Figure 3.10 shows the average values of peak oxidation currents obtained after incubation
from each of the barrel of three separate electrodes incubated in each of the
abovementioned solutions. From the evaluation of figure 3.10 we can deduce that each of
the barrels showed highly specific recognition properties. The signal obtained due the
non-specific adsorption of non-Aβ proteins and non-corresponding Aβ isoforms from
each of the barrels was found to be minimum and statistically insignificant.
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Figure 3.10. Oxidation peak current obtained from three anti-Aβ modified carbon fiber microelectrodes
after being incubated with 1 μM of Aβ1-40, 1μM of Aβ1-42 and 500nM of Aβ1-40 + 500 nM of Aβ1-42
spiked into rat cerebrospinal fluid solutions respectively. Measurements were performed in 10 mM PBS
buffer and 1mM KCl versus Ag/AgCl.

The stability of the microelectrodes with anti-Aβ antibodies immobilized on their surface
was evaluated over a period of one month. The micro immunosensors were stored in 0.1
M PBS solution at 4 oC after fabrication. The stability of the stored electrodes was
studied by incubating them in freshly prepared solution containing 0.1 % BSA, 500 nM
Aβ1-40, 500 nM Aβ1-42 in 0.1 M PBS at pH 7.2. The stability of the electrodes was
evaluated by measuring their electrochemical response using square wave voltammetry.
The electrochemical response of the microelectrodes progressively degraded after 4 days
in storage. To test the inter-sensor reproducibility of the proposed system, three samples
of different concentrations (100, 500 and 1000 nM) of Aβ1-40 and Aβ1-42 were tested
first with different electrodes. This indicates that our detection strategy offers an
acceptable reproducibility towards the detection of Aβ1-40 and Aβ1-42.
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3.4. Conclusion
In this work, a simple, sensitive and fast electrochemical multiplexed immunoaasay for
Alzheimer’s disease biomarkers is presented. The current signal generated due to the
oxidation of Aβ was demonstrated to be feasible in the development of a direct, one-step
biosensor. The reagentless detection process based on the inherent electroactivity of Aβ
greatly simplifies the sensor utilization. The incorporation of an electric field-driven
strategy greatly shortened the sensor fabrication and response time to 7 minutes enabling
real-time measurement of Aβ. The results show detection limit of sensor towards Aβ-40
and Aβ-42 to be 400 nM and 100nM respectively. The single use sensor displays
specificity towards respective Aβ isoform and no cross-talk between the barrels of the
microelectrode. The detction strategy enables the direct detection of electroactive
biomolecules and can be generally used for the detection of any other electroactive
biomarker by using an appropriate antibody. The limitations of the detection strategy are
that sensitivity is compromised as compared to the approach described in Chapter 2, due
to direct measurement. In addition, incubation time of 7 minutes is still long as some
biological reactions occur on the scale of seconds. To remedy these shortcomings the
direct dtection strategy was developed in Chapter 4.
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Chapter 4
Assessment of oxidative DNA damage and repair at single cellular level via real-time
monitoring of 8-OHdG biomarker
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4.1. Introduction
Reactive oxygen species (ROS) or free radicals have been implicated as the cause of
cancer, diabetes, cardiovascular disease, and neurodegenerative diseases (Wu et al.,
2004). In living cells, endogenous ROS are produced as a result of various metabolic,
physiological processes, and other biochemical reactions. The cell can protect itself from
ROS using enzymes such as superoxide dismutases, catalases, lactoperoxidases, and
glutathione peroxidases. Antioxidants such as ascorbic acid, tocopherol, glutathione and
uric acid present in the cell, act as scavengers of ROS (Jackson and Loeb, 2001). Under
normal physiological conditions a balance is maintained between the endogenous ROS
and antioxidants. However, an imbalance can be caused due to a drop in the level of
antioxidants or an increase in the level of ROS from exogenous sources such as cigarette
smoke, UV or ionizing radiation, hazardous chemicals, inflammation, etc. (Martin and
Barrett, 2002). When an imbalance occurs lipids, proteins and nucleic acids present in
the cell may undergo oxidative damage. The site of oxidative damage is usually nuclear
and mitochondrial DNA in tissue. Numerous DNA damage products are formed during
oxidative damage due to bases and sugar modifications, covalent crosslinks, single and
double stranded breaks. However, most research interest has focused on nucleobase
modifications (Cooke et al., 2003). Among the common DNA nucleobases, guanine has
the lowest oxidation potential and is the most prone to oxidative damage. Nucleobases
such as 8-hydroxyguanine (8-OxoG) are less common but act as deep traps for radical
cations since they have a much lower oxidation potential than guanine (Kanvah and
Schuster, 2006). Upon oxidation of 8-OxoG, a hydroxyl group is added to the 8th
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position of the guanine molecule and the oxidatively modified product is called 8-OHdG
(Floyd et al, 1986). DNA damage lesions such as 8-OHdG are recognized and cleaved by
the base excision repair mechanism (BER). Once recognized, 8-OHdG is cleaved by
enzymes such as endonuclease and glycosylase to prevent DNA mutations (Hollstein et
al., 1991; Cheng et al., 1992). 8-OHdG being water soluble is secreted out of the cell into
the extracellular space after being removed from the DNA helix.

Thus monitoring

extracellular 8-OHdG will provide insight into oxidative DNA damage (formation of 8OHdG) and DNA repair mechanisms (cleavage of 8-OHdG) (Zhang et al., 2006).
8-OHdG was first discovered by Kasai and Nishimura in 1984 during their attempt to
study and isolate mutagens in heated glucose (Kasai et al., 1984). Thereafter, numerous
papers have analyzed 8-OHdG levels in human organs, cell lines, and body fluids in
relation to oxidative stress, diet, cancer incidence, aging, heart disease and neurological
disorders. On account of these studies, 8-OHdG has been established as a crucial
biomarker of oxidative stress (Kasai, 1997; Shigenaga et al., 1989), cancer instigation by
free radicals (Halliwell 1998; Marnett 2000), and aging including degenerative diseases
(Fraga et al., 1990; Sayre et al., 2001). 8-OHdG is also a biological marker of lifestyle
and the effects of diet (Kasai et al., 2001; Halliwell, 2002). The significance of 8-OHdG
is such that a search done on Google Scholar for articles published during the last 20
years showed about 6,680 papers.
Electrochemical detection of 8-OHdG is possible as it undergoes oxidation via a twoelectron two-proton charge transfer reaction, shown in figure 4.1. (Goyal et al., 1997).
Due to the dissociation of protons the oxidation potential of 8-OHdG is heavily
dependent upon the pH of the supporting electrolyte (Li et al., 2007). The rate of the
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charge transfer reaction has been observed to be fastest at the surface of carbonaceous
electrodes (Langmaier et al., 2003). Carbon-fiber microelectrodes were introduced by
Pujol et al. nearly 30 years ago, who used them with normal pulse polarography to
measure the oxidation of several neurotransmitters, including dopamine, norepinephrine
and serotonin (Ponchon et al., 1979). Since then, the most popular applications for carbon
fiber electrodes have been as sensors for in-vivo detection of neurotransmitters. Carbon
fiber microelectrodes have been used for biological applications due to advantages such
as: excellent biocompatibility and non-toxicity towards cells, good electrochemical
properties which have been extensively studied and characterized, miniature size (<10
μm in diameter) of electrodes makes them ideal for implantation with minimal damage to
cells, enable rapid measurements when used with fast electrochemical techniques such as
amperometry, chronoamperometry and fast scan cyclic voltammetry.

Figure 4.1. Schematic showing the electroactive behavior of 8-OHdG.

Classic analytical methods used for the detection of 8-OHdG include high-performance
liquid chromatography with electrochemical detection (HPLC-ED) (Martinis and De
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Lourdes, 2002), gas-chromatography-mass spectroscopy (GC-MS) (Teixeira et al., 1993),
enzyme-linked

immunosorbent

assay

(ELISA)

(Chiou

et

al.,

2003),

immunohistochemical methods (Toyokuni et al., 1997), and single cell gel
electrophoresis (comet assay) (Hartmann et al., 1998). These methods have been
successfully used to analyze 8-OHdG in animal and human organs, fluid samples (urine,
saliva, and cerebrospinal fluid) and cell lysates. Techniques such as ELISA, HPLC-ED,
and GC-MS when used to monitor 8-OHdG levels in cell lysates or cell media report the
average behavior of cells in a population, thus concealing any cell to cell variations that
may characterize each cell’s survival under stress. Current techniques to determine 8OHdG in single cells are immunostaining, and comet assay. These techniques can
monitor cells only at a single time point and therefore do not allow for real-time
monitoring. Also, these techniques have been developed to look at the intracellular 8OHdG deposits. To overcome the disadvantages of the current techniques, we report a
strategy to measure extracellular levels of 8-OHdG in real time.
In our previous studies, we have successfully used carbon fiber microelectrodes to detect
analytes such as vascular endothelial growth factor and nitric oxide (Prabhulkar et al.,
2009; Li et al., 2009). Activated carbon nanotube based electrodes have been effectively
used for the simultaneous detection of neurotransmitters (Alwarappan et al., 2009;
Alwarappan et al., 2010). In this study, we have detected extracellular 8-OHdG secreted
from single lung epithelial cells exposed to varying concentrations of nicotine using
carbon fiber microelectrodes. Cigarette smoking and chewing tobacco have been linked
to the development of several cancers such as lung, oral, esophageal and bladder
(Boffetta et al., 2005; Campain, 2004). Nicotine, which is responsible for the addictive
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nature of tobacco use, is also one of the most biologically active chemicals present in
cigarette smoke and smokeless tobacco. Due to its highly reactive nature, nicotine has
been implicated in free radical generation in rodent and human cells of various types
(Wetscher et al., 1995; Wetscher et al., 1995; Ferger et al., 1998). Nicotine is also the
precursor to many tobacco carcinogens (Wu et al., 2005). Most of the research conducted
to determine the mutagenicity of nicotine shows inconsistent findings (Doolittle et al.,
1995; Trivedi et al., 1990). Therefore, there is a need for further exploration to clarify this
issue.
4.2. Experimental
4.2.1 Materials
Carbon fibers (5 μm in dia.) were friendly donated by World Precision Instruments
(Sarasota, FL). Borosilicate glass capillaries (outer dia. 0.5 mm, inner dia 0.3 mm) were
obtained from Sutter Instrument Company (Novato, CA). Sylgard 184 was obtained from
Dow Corning Corporation (Midland, MI). Human alveolar epithelial cell line L-132 was
purchased from American Type Culture Collection (VA, USA). Dulbecco's Modified
Eagle Medium and 10 % heat-inactivated fetal bovine serum were purchased from Gibco
BRL (Grand Island, NY). 8-OHdG stock solution was obtained from Biolog Inc.
(Hayward, CA) at a concentration of 5 μmol. Calcium Ionophore (A23187), hydrogen
peroxide (≥97%), nicotine (≥9 9%), and other reagents were purchased from SigmaAldrich (St. Louis, MO).
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4.2.2 Instrumentation
Carbon fiber microelectrodes were prepared using P-97 Micropipette Puller and BV-10
Beveller acquired from Sutter Instrument Company (Novato, CA).

Electrochemical

measurements were carried out using the 600C Electrochemical Analyzer attached to a
Picoamp Booster from CH Instruments, Inc. (Austin, TX). PV830 Pneumatic Picopump
purchased from World Precision Instruments (Sarasota, FL). LU-CB1 Leiden
microincubator purchased from Harvard Apparatus (Holliston, MA). MS3114
micromanipulators purchased from World Precision Instruments (Sarasota, FL), one to
position the working electrode for the cell and the second to position the injection pipette
containing the secretagogue. Faraday Cage and Anti-Vibration Workstation purchased
from Kinetic Systems, Inc. (Boston, MA). A conventional three electrode cell consisting
of an Ag/AgCl reference electrode (3 M KCl) (Bioanalytical Systems, IN, USA), and a
platinum wire as an auxiliary electrode was employed.

4.2.3. Preparation and activation of carbon fiber microelectrodes
Carbon fiber microelectrodes were fabricated using the method described in our previous
work (Prabhulkar et al., 2009). Briefly, a single carbon fiber of diameter 5 μm was
attached to the stripped end of an insulated copper wire (dia. 0.2 mm) using a silver
conductive paste. The silver paste was allowed to dry, after which the free end of the
copper wire was cannulated into a borosilicate glass capillary. The copper wire was fixed
to the capillary using a fast drying epoxy resin. The capillary was then pulled using a
micropipette puller. This pulling procedure results in two glass pipettes, one of which is
discarded, and the other part which holds the carbon fiber protruding from its tip. The
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junction between the carbon fiber and capillary is sealed with a drop of the Sylgard
silicone preparation and allowed to cure until it becomes firm. The microelectrodes were
then beveled at 45o using diamond abrasive plate, to obtain a disk shaped active electrode
surface. The carbon fiber surface was then cleaned by 5 second sonication in acetone, 1
M nitric acid, 1 M KOH and distilled water sequentially. The microelectrodes were
electroactivated using a 150 mM NaCl solution (pH=10) at 1.2 V (vs. Ag/AgCl) for 8
minutes at room temperature.

4.2.4. Cell culture of lung endothelial cells
Human alveolar epithelial cells were cultured in Dulbecco's Modified Eagle Medium
supplemented with 10% heat-inactivated fetal bovine serum. The cells were stored at
37 °C in 5% CO2, 95% O2 in a humidified cell incubator. The cell medium was changed
every 48 hours.

4.2.5. Calibration of microelectrode for 8-OHdG measurements
Standard solutions of different concentrations (10 pM, 20 pM, 30 pM, 40 pM, 50 pM and
60 pM) were made by gradually diluting the 8-OHdG stock solution using 0.1 M
phosphate buffer saline (PBS) at pH=7, which correlates to physiological pH. Calibration
of the microelectrode for 8-OHdG detection was carried out using CPA, with the
potential on the microelectrode held at 0.42 V (vs. Ag/AgCl). The microelectrode to be
tested and a microcapillary (inner diameter 20 μm) were both placed in petri dish
containing saline buffer (137 mM NaCl, 5 mM KCl, 0.7 mM Na2HPO4, 25 nM HEPES,
10 mM glucose, 2 mM CaCl2 at pH=7.2). The tip of the carbon fiber microelectrode was
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placed at the outlet of the microcapillary as shown in figure 4.2. The microcapillary
filled with 8-OHdG standard solution was connected to the PV830 Pneumatic Picopump.
This calibration system was used to simulate the situation of 8-OHdG detection near the
surface of a single cell.

Figure 4.2. View of calibration system to measure 8-OHdG response at the surface of an activated carbon
fiber microelectrode.

4.2.6. Single-cell measurements
Prior to experimentation, cell culture media was discarded and the petri dishes (35 mm
outer diameter X 10 mm high) containing 1 x 102 cells were rinsed twice with a saline
buffer. The petri dish was refilled with saline buffer warmed to 37 oC and placed on the
LU-CB1 Leiden microincubator. The microincubator placed on the stage of an inverted
microscope, maintains the cell bath temperature to 37 oC and the CO2 content to 5%. A
single isolated cell was located with the microscope and an activated carbon fiber
microelectrode was positioned at a distance 0.5 μm over its surface using the MS3114
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micromanipulators as shown in figure 4.3. All the experiments were isolated from
electromagnetic interference and physical disturbances using a Faraday Cage and an
Anti-Vibration Workstation. Any cables running into the Faraday Cage were additionally
shielded using aluminum tape. Secretagogues, such as Calcium Ionophore (A23187) were
applied to the cell via pressure ejection from the tips of micropipettes (inner diameter 20
μm) placed at a distance of 1 cm from the cell. Flow rate through the pipette tips was
determined to be 0.2 μL/s. Hydrogen peroxide was used as a positive control to induce
oxidative DNA damage while a saline buffer was used as a negative control. Cells were
treated with 10 mM hydrogen peroxide dissolved in the cell bath solution. Nicotine was
introduced at varying concentrations into the cell bath solution in order to study its effects
on DNA damage and 8-OHdG secretion.

Figure 4.3. View of the detection system in single cell experiments. A carbon fiber microelectrode was
placed at a fixed distance of 0.5µm away from the surface of a cell.
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4.2.7. Electrochemical measurements
CPA in conjunction with Fast Scan Cyclic Voltammetry (FSCV) was used to monitor 8OHdG release from single cells. CPA was performed by holding the microelectrode at
constant potential of 0.42 V. FSCV was performed in the potential window of 0.2 to 0.8
V, at a scan rate of 200 V/s. Background CPA and FSCV measurements were conducted
at the surface of the cell in bath buffer before addition of hydrogen peroxide or nicotine.
In order to eliminate noise and enhance signal the background measurements were
subtracted from the averaged CPA and FSCV measurements conducted at cells under the
influence of hydrogen peroxide or nicotine

4.3. Results and discussion
4.3.1 Calibration for 8-OHdG
A typical amperometric response to the injection of 8-OHdG is shown in figure 4.4. After
each injection the activated carbon fiber microelectrode displayed a quick amperometric
response which reaches a maximum plateau value and then rapidly drops. A calibration
curve of peak amperometric response against the corresponding 8-OHdG standard
solution concentration was plotted in figure 4.5. The calibration curve indicates that the
activated microelectrode displayed a linear response from 10 pM to 60 pM solution of 8OHdG. The linear response of the microelectrode proves that it is well suited for the
direct detection of 8-OHdG.
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Figure 4.4. Typical amperometric response to the injection of 10 pM, 20 pM, 30 pM, 40 pM, 50 pM, and
60pM 8-OHdG by using the calibration system.

Figure 4.5. The calibration curve for microelectrode response towards 8-OHdG solution over the
concentration range of 10–60 pM.
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4.3.2. Detection of 8-OHdG secretion from single lung epithelial cells
Initially, in order to establish a negative control or background readings, electrochemical
measurements were conducted at the surface of a single isolated cell incubated in saline
buffer. An activated carbon fiber microelectrode (working electrode) was positioned at
0.5 µm above the cell surface, Ag/AgCl electrode (reference electrode) and a 0.5 mm
diameter platinum wire (counter electrode) were also placed in the saline buffer. Calcium
ionophore (A21387) was used in order to stimulate exocytosis in cells.

A21387

facilitates the influx of Ca2+ from the bath buffer into the cell. This results in an
escalation of free intracellular Ca2+ which triggers rapid exocytosis. 500 µM calcium
ionophore dissolved in dimethyl sulfoxide was injected at rate of 0.2 μL/s at a distance of
1 cm from the cell under study using the Picopump. The actual concentration of
ionophore affecting the cell would be far less due to its diffusion into the cell bath
solution. Secretion of 8-OHdG from the single cell surface was mapped using CPA and
FSCV. Cells were monitored using CPA for a period of 2 hours with calcium ionophore
stimulation applied every 100 seconds. Figure 4.6. shows the CPA response of the
microelectrode recorded at the surface of a single lung cell incubated in saline buffer. We
do not observe any current peaks higher than the background signal, which indicates that
significant secretion of 8-OHdG from cell was not observed in the saline buffer.
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Figure 4.6. Current recordings made at a single lung endothelial cell in saline buffer with the electrode
potential was held at +0.42 V. The bars indicate calcium ionophore injection via microcapillary placed 1
cm from cell surface.

Hydrogen peroxide was used as a positive control or model ROS to induce oxidative
damage in lung epithelial cells (Halliwell and Aruoma, 1991). Hydrogen peroxide has
been proven to cause DNA strand breakage and is highly correlated with multiple
chemical modifications of DNA bases, suggesting damage due to hydroxyl radical
(Spencer et al., 1995). In order to induce oxidative DNA damage, lung epithelial cells
were subjected to 10 mM hydrogen peroxide solution made using saline buffer.
Electrochemical recording was started 15 minutes after incubating cells with saline
solution containing hydrogen peroxide. Hydrogen peroxide was present in the cell bath
during the entire course of the CPA measurements. These experiments were conducted as
a proof of concept to verify if 8-OHdG release could be recorded from a single lung
epithelial cell. CPA was conducted at the cell surface using calcium ionophore
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stimulation. From the background subtracted CPA signal shown in figure 4.7., we
observe that 8-OHdG is sporadically released after stimulation. The average peak current
calculated by taking into account peaks obtained during the first three stimulations given
to 20 different cells is 6.17±0.5 pA.

Figure 4.7. Current recordings made at single lung endothelial cell with 10mM hydrogen peroxide
exposure. The bars indicate calcium ionophore injection via microcapillary placed 1 cm from cell surface.

We also conducted repetitive FSCV measurements at the surface of the cells. The
background subtracted voltammogram shown in figure 4.8. shows an oxidation peak at
0.42 V (Ag/AgCl) which corresponds to the electrochemical behavior of 8-OHdG (Li et
al., 2007; Wan et al., 2008; Brett et al., 2000). Therefore, using CPA we were able to
record the release kinetics of 8-OHdG from the surface of a single lung epithelial. Based
on the oxidation peak observed in the background subtracted FSCV signal, we are able to
verify that the analyte being measured by the microelectrode is in fact 8-OHdG.
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Figure 4.8. Background subtracted fast scan cyclic voltammogram at the surface of single lung epithelial
cell incubated with 10mM hydrogen peroxide. The potential sweep was carried out from 0.2 to 0.8 V, at a
scan rate of 200 V/s.

4.3.3. Test effects of nicotine on oxidative DNA damage and repair / Test effects of
nicotine on 8-OHdG secretion
The concentration of nicotine in the plasma and saliva of smokers can reach up to 100
ng/mL (0.0006 mM) and 4000 ng/ml (0.025 mM), respectively (Hukkanen et al., 2005;
Schneider et al., 2001; Teneggi et al., 2002). In order to conduct our studies at a
physiologically relevant range, we have tested lung epithelial cell exposure to 0.025,
0.05, 0.1, 0.5, 1, 2, 4, 6 and 8 mM of pure nicotine dissolved in the saline cell bath buffer.
In order to study the time release kinetics of 8-OHdG secretion, single lung epithelial
cells were monitored up to a period of 2 hours. Figure 4.9. shows the image of a healthy
attached cell present in saline buffer solution, recorded two hours after the petri dish was
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placed on the microincubator. This image demonstrates that the lung epithelial cells are
healthy for the entire duration of the electrochemical investigation.

Figure 4.9. Image of single lung epithelial cell in saline buffer solution, recorded 2h after the petri dish was
placed on the microincubator.

4.3.3.1. Concentration effects of nicotine
Nicotine was dissolved in the saline buffer to obtain standard test solutions from 0.025 to
8 mM. Figure 4.10. shows the background subtracted CPA signal recorded at the surface
of a single lung epithelial cell exposed to 4mM nicotine solution. Therefore, we
confirmed that 8-OHdG is released from a single cell under the influence of nicotine,
after calcium ionophore stimulation.
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Figure 4.10. Current recordings made at a single lung endothelial cell in saline buffer with the electrode
potential was held at +0.42 V. The bars indicate calcium ionophore injection via microcapillary placed 1
cm from cell surface.

Figure 4.11. shows results of average peak currents obtained from 3 individual cells
subjected to each standard nicotine solution for a period of 1 hour. We did not observe
any peaks greater than the background signal for exposure to nicotine solution of 0.025,
0.05, 0.1, 0.5, and 1 mM of nicotine solutions. However 8-OHdG secretion displayed a
dose related response for nicotine exposures of 2, 4, 6 and 8 mM. Instantaneous cell
detachment was observed for nicotine exposures over 9 mM, as shown in figure 4.12.
These results are in concordance with studies performed by Yildiz, to compare the
formation of 8-OHdG in Chinese Hamster Ovary cells due to nicotine and smokeless
tobacco extract containing the same amounts of nicotine (Yildiz, 2004).
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Figure 4.11. Average peak currents obtained from 3 individual isolated cells after 1 h of incubation with
0.025, 0.05, 0.1, 0.5, 1, 2, 4, 6, and 8mM nicotine solution respectively.

Figure 4.12. Image of detached and unhealthy lung epithelial cells, recorded after the addition of 9mM
nicotine solution.

4.3.3.2. Time effects of 8-OHdG nicotine induced measurements
CPA was used to study the release kinetics of 8-OHdG from single lung epithelial cells
exposed to 4 mM of nicotine, as shown in Fig. 4.13. A 4 mM nicotine solution was
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selected to study the time release kinetics as this concentration of nicotine lies at the
center of the damage causing range of 2 to 8 mM, as observed from our previous
experiments. 20 individual isolated cells were studied under similar experimental
conditions for a period of 2 hours. The same carbon fiber microelectrode was used to
study each of the cells to eliminate any variability due to sensor response. The carbon
fiber microelectrode was cleaned and pretreated before analyzing every cell. Calcium
ionophore stimulation was given every 100 seconds. The first 8-OHdG secretion peaks
were observed at an average time period of 12.37±1.5 minutes as shown in Fig. 4.13.
The amount of 8-OHdG secreted thereafter escalated until it reached a plateau period
between 47±2.3 and 82±2.3 minutes. Following the plateau, 8-OHdG secretion
decreased and finally ceased after an average of 110±3.8 minutes. The cessation of 8OHdG secretion can be related to the inhibition of DNA repair by the base excision repair
pathway. DNA repair suppression has also been reported during exposure of cells to
oxidants such as hydrogen peroxide (Hu et al., 1995; Li et al., 2000), formaldehyde
(Grafstrom et al., 1983) and nicotine (Kozlovskis-Wade et al., 1998).
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Figure 4.13. Average current recordings made at the surface of 20 single isolated lung epithelial cells with
4mM nicotine exposure for a period of 2 h.

4.4. Conclusions
In this study, we have monitored the release kinetics of 8-OHdG at the surface of a single
lung epithelial cell using an activated carbon fiber microelectrode. To the best of our
knowledge, this is the first report showing direct and continuous measurements of 8OHdG release at the surface of a single isolated cell. Activated carbon fiber
microelectrodes exhibit excellent sensitivity towards 8-OHdG, discerning currents as
small as 1 pA. FSCV conducted to verify the release of 8-OHdG showed an oxidation
peak at 0.42 V. Lung epithelial cells were incubated with varying concentrations of
nicotine in order to study its genotoxic effects. Nicotine showed a dose dependent
increase in DNA damage which was mirrored in the amount of 8-OHdG secreted.
Studying the temporal release kinetics reveals cessation of 8-OHdG after 110 minutes of
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exposure to 4 mM nicotine. We have outlined a highly sensitive strategy for the real time
measurements of 8-OHdG at a single cell level. It is hopeful that a similar strategy may
be employed to detect 8-OHdG in-vivo. Multiple carbon fiber nanoelectrodes may also
be used to determine spatial distribution of 8-OHdG release from a single cell.
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Chapter 5
Conclusions and Future Work

5.1. Conclusions
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Electrochemical sensors developed to measure disease biomarkers allow us to diagnose
and study diseases such as cancer and Alzheimer’s. Electrochemical detection allows
highly sensitive, real-time detection of biomarkers in solution and at the surface of single
cells. Incorporation of antibodies to the sensor surface enhances sensitivity and imparts
specificity. This thesis mainly deals with the development of direct, one-step
microsensors towards measurement of disease biomakers.
Chapter 2 deals with the development of a direct reagentless immunosensor for the
detection of VEGF. A highly sensitive, reagentless, electrochemical strategy is reported
for the detection of a cancer biomarker VEGF. Disc shaped carbon fiber microelectrodes
were used as the immunosensor platform. Ferrocene monocarboxylic acid labeled antiVEGF was covalently immobilized on the microelectrode surface using a Jeffamine
cross-linker. The formation of immuno- complexes leads to a decrease in the
electrochemical signal of ferrocene monocarboxylic acid owing to increased spatial
blocking of microelectrode surface. These signal changes enable quantitative detection of
VEGF in solution. Voltammetric measurements were conducted to evaluate the
interfacial immunore- actions and to quantitatively detect VEGF biomarker. The
proposed immunosensing strategy allows a rapid and sensitive means of VEGF analysis
with a limit of detection of about 38 pg/mL. This opens up the possibility of employing
these electrodes for various single cell analysis and clinical applications. Further,
experimental conditions such as concentration of the immobilized antibodies and
incubation period were optimized. Following this, the stability and specificity of the
immunosensors were also evaluated.
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Chapter 3 describes the development of a multiplex, direct immunosensor for the
detection of Aβ isoforms which are key biomarkers related to AD. AD affects about 35.6
million people worldwide, and if current trends continue with no medical advancement, 1
in 85 people will be affected by 2050. Thus, there is an urgent need to develop a cost
effective, easy to use, sensor platform to diagnose and study AD. The measurement of
peptide Aβ found in CSF has been assessed as an avenue to diagnose and study the
disease. The quantification of the ratio of Aβ1-40/42 (or Aβ ratio) has been established as
a reliable test to diagnose AD through human clinical trials. Therefore we have developed
a multiplexed, implantable immunosensor to detect Aβ isoforms using triple barrel
carbon fiber microelectrodes as the sensor platform. Antibodies act as the biorecognition
element of the sensor and selectively capture and bind Aβ1-40 and Aβ1-42 to the
electrode surface. Electrochemistry was used to measure the intrinsic oxidation signal of
Aβ at 0.65 V (vs Ag/AgCl), originating from a single Tyr residue found at position 10 in
its amino acid sequence. Using the proposed immunosensor Aβ1-40 and Aβ1-42 could be
specifically detected in CSF from mice within a detection range of 100nM to 1.2μM and
400nM to 1μM respectively.

The immunosensor enables real-time, highly sensitive

detection of Aβ and opens up the possibilities for diagnostic ex-vivo applications and
research-based in-vivo studies.
Chapter 4 involves the mesurement of DNA damage biomarker 8-OHdG at the surface of
single cells under the influence of ROS. 8-OHdG is the most important and bestdocumented biomarker of oxidative stress, which is involved in the instigation of various
diseases. 8-OHdG levels correlate to oxidative DNA damage which is known to be the
root cause of a variety of age-related chronic diseases. The purpose of our research was to
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develop a detection strategy capable of measuring 8-OHdG in real-time at the surface of a
single cell. Activated carbon fiber microelectrodes were used as the sensing platform.
The microelectrodes were used to measure 8-OHdG release from single lung epithelial
cells under the influence of nicotine. In order to evaluate the direct role of nicotine in
tobacco induced genotoxicity, we studied the influence of parameters such as nicotine
concentration and exposure times on 8-OHdG secretion. 2–8 mM nicotine solutions
induced dose-dependent DNA damage in single cells, which was observed via
amperometric measurements of secreted 8-OHdG biomarker. Real-time 8-OHdG
measure- ments from single cells exposed to 4 mM nicotine solution revealed cessation
of 8-OHdG secretion after 110 min. We have successfully outlined a methodology to
detect 8-OHdG at the surface of single cells. A similar protocol can be used to evaluate
oxidative DNA damage and repair mechanisms in other disease models.

5.2. Future Work
The multiplex sensor developed for the detection Aβ isoforms will be further tested invivo using amyloid precursor protein transgenic mice. The triple barell sensors will
further used to study the effects of drug candidates on Aβ production or clearance.
Electrochemical measurements of 8-OHdG at the surface of single cells will be using
chip based microfluidic sensors. Micro-wells capable of capturing a single cell and
containing a gold/carbon electrode at the base of the well will be fabricated. 8-OHdG
measurements will be performed under the effects of anti-oxidants and pro-oxidants.
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